{"status":200,"message":"获取成功","debug":"获取成功象","list":[{"id":"2c923cff948c7f1c0196c406516b0274","createTime":1747072800000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/12cd0bc4-d2c1-4e8a-9869-87e5c81c9d02.jpg","title":"ISBT 2025","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"June 1-4, 2025","expand2":"Allianz MiCo Convention Centre，Piazzale Carlo Magno 1，20149 Milano，Italy"},{"id":"2c923cff948c7f1c0196c402dc0e0272","createTime":1747065600000,"updateTime":1747045293000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/53efe934-77e7-4e5d-a4a5-f1724b179d29.jpg","title":"Euroanaesthesia 2025","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"May 25-27, 2025","expand2":"Centro the Congressos de Lisboa (CCL) "},{"id":"2c923cff948c7f1c0196c3ff9b200270","createTime":1747044960000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/9c499551-7d06-416d-85a8-13d9605eb81a.jpg","title":"Hospitalar 2025","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"MAY 20-23, 2025","expand2":"SÃO PAULO EXPO – EXHIBITION & CONVENTION CENTER"},{"id":"2c923cff948c7f1c0196c3fb8f76026e","createTime":1746979200000,"updateTime":1747045298000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/5bc315fc-50b0-4c38-87a2-ddc844f97c8a.jpg","title":"EUROMEDLAB 2025","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"May 18-22, 2025","expand2":"Brussels Expo"},{"id":"2c923cff948c7f1c0195eb5e155b01bf","createTime":1743501600000,"updateTime":1743410612000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/fe584ac5-2f45-4768-9607-5c5e02f6d2c9.png","title":"CMEF 2025","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"April 8-11, 2025","expand2":"National Exhibition and Convention Center, Shanghai, China"},{"id":"2c923cff948c7f1c01957f2a77760102","createTime":1742004000000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/6ad1d4cf-5bdc-4329-832a-e5f81213cb9f.jpg","title":"The 22nd China Association of Clinical Laboratory Practice Expo (CACLP)","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"22-24 March 2025","expand2":"Hangzhou Grand Convention & Exhibition Expo Center"},{"id":"2c923cff948c7f1c01948cd265c0002f","createTime":1737075600000,"updateTime":1737600028000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/21c5ffda-b736-412f-a359-41a5bb84cbca.jpg","title":"VMX 2025 General Show","subTitle":"","html":"

<\/p>

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"January 25-29, 2025","expand2":"Booth 1438, North/South Building, Orlando, FL"},{"id":"2c923cff8e5b65aa01946da07f7e02df","createTime":1736956800000,"updateTime":1737006334000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/fc4acf91-3777-44fe-9c6a-411a487cf56a.jpg","title":"Arab Health 2025","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"January 27 -30, 2025","expand2":"Dubai World Trade Center, Dubai, UAE"},{"id":"2c923cff8e5b65aa01946da3d11402e0","createTime":1736870400000,"updateTime":1737006308000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/9f84aef3-7337-46e7-861a-63a6e0439141.jpg","title":"Medlab Middle East 2025","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"3-6 February, 2025","expand2":"Dubai World Trade Center, Dubai, UAE"},{"id":"2c923cff8e5b65aa019300b25ce60243","createTime":1730854800000,"updateTime":1730883627000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/6f59fbea-d9bf-408a-9672-37d4056b3980.png","title":"MEDICA 2024","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"November 11-14,2024","expand2":"Düsseldorf, Germany"},{"id":"2c923cff8e5b65aa01923c528c5601f8","createTime":1727712000000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/904ba4cf-6b30-487d-84cd-e7b368b5e1de.png","title":"CMEF 2024","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"October 12-15,2024","expand2":"Shenzhen World Exhibition & Convention Center"},{"id":"2c923cff8e5b65aa01907c5a574b011c","createTime":1722268800000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/75158211-ab82-48a9-aa1c-4c3a759a150f.jpg","title":"ADLM 2024 (formerly AACC)","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"July 30-August 1, 2024","expand2":"McCormick Place, Chicago"},{"id":"2c923cff8e5b65aa018fa92cc5d300b1","createTime":1720591200000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/11215a72-57b7-4016-b984-4fdc946c9fb5.jpg","title":"Medlab Asia & Asia Health 2024","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"July 10-12, 2024","expand2":"Queen Sirikit National Convention Center (QSNCC), Bangkok, Thailand"},{"id":"2c923cff8e5b65aa018f9faf929c00ad","createTime":1719136800000,"updateTime":1716885561000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/1306da89-3f51-454e-93c1-d8823888bc4e.jpg","title":"ISBT 2024","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"June 23-27, 2024","expand2":"Centre de Convencions International de Barcelona"},{"id":"2c923cff8e5b65aa019010670eb100e3","createTime":1718265600000,"updateTime":1718272051000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/a748d703-5c4d-4e3c-9539-713e50a2bb41.jpg","title":"British Consul-General and Delegation Visit Medcaptain ","subTitle":"This visit highlighted the strong ties between Medcaptain and the UK, looking forward to a future of collaboration.","html":"

<\/span><\/p>

<\/span><\/p>

On June 12th, Ms. Sarah Mann, His Majesty's Consul-General to Guangzhou, along with Mr. Mike McCourt, Director of Healthcare, Department for Business and Trade, visited the headquarters of Medcaptain. They engaged in extensive discussions with Mr. Michael Zhong, Executive Vice President of Medcaptain, and his team.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/span><\/p>

Ms. Sarah Mann expressed her profound appreciation for the progress Medcaptain has achieved in recent years, particularly in product innovation and business expansion.
<\/span><\/p>

 <\/span><\/p>

In January 2022, Medcaptain completed the acquisition of Penlon, a globally renowned manufacturer of anesthesia and respiratory devices. After joining the Medcaptain family, this Oxford based company with a history of 80 years, has been revitalised, benefiting from integrated resource allocation and continuous empowerment within the group.<\/span> <\/span><\/span><\/p>

 <\/span><\/p>

Penlon has maintained, and is steadily enhancing its global competitiveness, from technological innovation and R&D, manufacturing and delivery, to marketing & promotion. <\/span><\/p>

 <\/span><\/p>

In the foreseeable future, with the launch of next generation high-ended anesthesia machines and other products, Penlon is expected to create more job positions and development opportunities in the local community. Ms. Mann has shown keen appreciation and high recognition for this development.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

<\/span><\/p>

Meanwhile, Mr. Mike McCourt expressed warm attention for the challenges Medcaptain is facing in its long-term investment and development in the UK. He stated that, depending on investment location, central & local government in the UK are very willing to support innovative and enterprising companies like Medcaptain in areas such as funding incentives, talent recruitment and product development.<\/span> <\/span><\/p>

 <\/span><\/p>

Mr. Michael Zhong said, "Medcaptain has always been committed to continuous improvement of technological innovation and solutions, as well as tirelessly promoting expansion into various niche fields, utilising our advance in technology. At the same time, in each strategic market around the world, we focus on both localized operations and collaborative development within the group.” <\/span><\/p>

 <\/span><\/p>

“The UK is a market of special significance and great importance to Medcaptain. We will continue to invest and make progress, contributing to the local social development."<\/span><\/p>

 <\/span><\/p>

This visit and the subsequent discussions highlighted the strong ties and mutual interests between Medcaptain and the UK, and we look forward to a future of collaboration and shared success.<\/span><\/p>


<\/span><\/p>


<\/p>


<\/p>","title4model1":"","html4model1":"

On June 12th, Ms. Sarah Mann, His Majesty's Consul-General to Guangzhou, along with Mr. Mike McCourt, Director of Healthcare, Department for Business and Trade, visited the headquarters of Medcaptain. They engaged in extensive discussions with Mr. Michael Zhong, Executive Vice President of Medcaptain, and his team.<\/span><\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

Ms. Sarah Mann expressed her profound appreciation for the progress Medcaptain has achieved in recent years, particularly in product innovation and business expansion. In January 2022, Medcaptain completed the acquisition of Penlon, a globally renowned manufacturer of anesthesia and respiratory devices. After joining Medcaptain family, this Oxford based company with a history of 80 years, has revitalised, benefiting from integrated resource allocation and continuous empowerment within the group. Penlon has maintained, and is steadily enhancing its global competitiveness, from technological innovation and R&D, manufacturing and delivery, to marketing & promotion. In the foreseeable future, with the launch of next generation high-ended anesthesia machines and other products, Penlon is expected to create more job positions and development opportunities in local community. Ms. Mann has shown keen anticipation and high recognition for this development.<\/span><\/p>


<\/span><\/p>

<\/p>

<\/p>

Meanwhile, Mr. Mike McCourt expressed warm attention for the challenges Medcaptain is facing in its long-term investment and development in the UK. He stated that central & local government in the UK are very willing to support innovative and enterprising companies like Medcaptain in areas such as financial management, talent recruitment and development, expecting that "Chinese wisdom" will sparkle in the UK.<\/span><\/p>

 <\/span><\/p>

Mr. Michael Zhong said, "Medcaptain has always been committed to continuous improvement of technological innovation and solutions, as well as tirelessly promoting expansion into various niche fields, utilising our advance in technology. At the same time, in each strategic market around the world, we focus on both localized operations and collaborative development within the group. The UK is a market of special significance and great importance to Medcaptain. We will continue to invest and make progress, contributing to the local social development."<\/span><\/p>

 <\/span><\/p>

This visit and the subsequent discussions highlighted the strong ties between Medcaptain and the UK, and we look forward to a future of collaboration and shared success.<\/span><\/p>


<\/p>

 <\/span><\/p>


<\/p>


<\/p>"},{"id":"2c923cff8e5b65aa018fbe9745f300c2","createTime":1716879600000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/28d0bfcc-cf7f-4e3a-9359-551ebe3094b5.jpg","title":" Medcaptain Medical Shines at Hospitalar, Innovative Solutions Garner Attention","subTitle":"","html":"

<\/p>


<\/p>

The 29th edition of the São Paulo International Medical Equipment Exhibition (Hospitalar 2024) took place in grand style at the São Paulo International Convention Center from May 21st to 24th, showcasing Medcaptain as one of the highlights. <\/p>


<\/p>

<\/p>

Medcaptain presented an array of cutting-edge solutions, including the XP series high-end intelligent infusion workstations, Vitavue series multi-parameter monitors, ELFensor P series portable infusion solutions, Penlon Prima 460 high-end anesthesia systems, and the VedVision endoscopic retrograde cholangiopancreatography (ERCP) system. Committed to providing a comprehensive medical solution, these innovations serve as invaluable tools for clinical diagnosis and treatment.<\/p>


<\/p>

With its significant market presence, Brazil stands as one of the largest medical markets in Latin America. Medcaptain, with its longstanding presence in the region, has earned widespread recognition and trust in the Brazilian market through its innovative product solutions, top-notch quality, and comprehensive after-sales service, delivering high-quality medical equipment and services to numerous local medical institutions.<\/p>


<\/p>

This expedition to Brazil not only showcased Medcaptain's prowess in the medical equipment field but also strengthened its collaboration with global partners. Looking ahead, Medcaptain remains dedicated to developing even more innovative and efficient medical equipment, making substantial contributions to the advancement of the global healthcare industry.<\/p>


<\/p>","title4model1":"","html4model1":"

<\/p>


<\/p>

The 29th edition of the São Paulo International Medical Equipment Exhibition (Hospitalar 2024) took place in grand style at the São Paulo International Convention Center from May 21st to 24th, showcasing Medcaptain as one of the highlights. <\/p>


<\/p>

<\/p>

Medcaptain presented an array of cutting-edge solutions, including the XP series high-end intelligent infusion workstations, Vitavue series multi-parameter monitors, ELFensor P series portable infusion solutions, Penlon Prima 460 high-end anesthesia systems, and the VedVision endoscopic retrograde cholangiopancreatography (ERCP) system. Committed to providing a comprehensive medical solution, these innovations serve as invaluable tools for clinical diagnosis and treatment.<\/p>


<\/p>

With its significant market presence, Brazil stands as one of the largest medical markets in Latin America. Medcaptain, with its longstanding presence in the region, has earned widespread recognition and trust in the Brazilian market through its innovative product solutions, top-notch quality, and comprehensive after-sales service, delivering high-quality medical equipment and services to numerous local medical institutions.<\/p>


<\/p>

This expedition to Brazil not only showcased Medcaptain's prowess in the medical equipment field but also strengthened its collaboration with global partners. Looking ahead, Medcaptain remains dedicated to developing even more innovative and efficient medical equipment, making substantial contributions to the advancement of the global healthcare industry.<\/p>


<\/p>


<\/p>"},{"id":"2c923cff8e5b65aa018fa44f8e2600af","createTime":1716620400000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/9754c118-26c4-4a12-ba27-64c8923ca5c9.jpg","title":"Euroanaesthesia 2024","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"May 25-27, 2024","expand2":"ICM-International Congress Center Messe München"},{"id":"2c923cff8e5b65aa018f9f6620fb00a6","createTime":1716278400000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/ef33c891-71b9-47cc-bc84-d94db8687c74.png","title":"Hospitalar 2024","subTitle":"","html":"

\"可能是包含下列内容的插图：上面的文字是“Vedkang<\/p>","title4model1":"","html4model1":"

\"可能是包含下列内容的插图：上面的文字是“Vedkang<\/p>","expand1":"May 21-24, 2024","expand2":"São Paulo Expo Exhibition & Convention Center"},{"id":"2c923cff8e5b65aa018f9f8ba14c00a8","createTime":1716278400000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/7859a0f6-627d-492c-b407-c40af1ed065e.jpg","title":"CSCCM 2024","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"May 9-12, 2024","expand2":"Tianfu International Convention Center (Chengdu·China)"},{"id":"2c923cff8e5b65aa018f9fab431a00ab","createTime":1715767200000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/82d443d2-2050-498a-a71a-8849537049bb.jpg","title":"Medcaptain donated a batch of medical devices to Kazakhstan","subTitle":"","html":"

Local time on Wednesday, May 15, with the aim of strengthening international medical cooperation, International Scientific and Practical Conference dedicated to the 35th anniversary of the National Medical Association Republican Public Union organised by the Ministry of Health, the Ministry of Emergency Situations and the National Medical University of Kazakhstan, was grandly held in Almaty, Kazakhstan.<\/p>


<\/p>

\"图片\"/
<\/p>


<\/p>

Nearly 100 representatives of medical associations from various countries, including China, watched a special multi-party tactical exercise by rescuers, psychologists, and medical staff, which demonstrated the professionalism and emergency response level of Kazakhstan's medical staff.<\/p>


<\/p>

\"图片\"/<\/p>

<\/p>


<\/p>

During the meeting, Medcaptain donated a batch of medical devices to the National Medical Association of the Republic of Kazakhstan, showcasing its commitment to global healthcare development.<\/p>


<\/p>

\"图片\"/<\/p>


<\/p>

In the future, Medcaptain will continue to plough into the Central Asian market, investing in product promotion, local service and team building to better understand the market and users' needs, and provide better solutions for local customers.<\/p>

\"图片\"/<\/p>","title4model1":"","html4model1":"

Local time on Wednesday, May 15, with the aim of strengthening international medical cooperation, International Scientific and Practical Conference dedicated to the 35th anniversary of the National Medical Association Republican Public Union organised by the Ministry of Health, the Ministry of Emergency Situations and the National Medical University of Kazakhstan, was grandly held in Almaty, Kazakhstan.<\/p>


<\/p>

\"图片\"/
<\/p>


<\/p>

Nearly 100 representatives of medical associations from various countries, including China, watched a special multi-party tactical exercise by rescuers, psychologists, and medical staff, which demonstrated the professionalism and emergency response level of Kazakhstan's medical staff.<\/p>


<\/p>

\"图片\"/<\/p>


<\/p>


<\/p>

During the meeting, Medcaptain donated a batch of medical devices to the National Medical Association of the Republic of Kazakhstan, showcasing its commitment to global healthcare development.<\/p>


<\/p>

\"图片\"/<\/p>


<\/p>

In the future, Medcaptain will continue to plough into the Central Asian market, investing in product promotion, local service and team building to better understand the market and users' needs, and provide better solutions for local customers.<\/p>

\"图片\"/<\/p>


<\/p>"},{"id":"2c923cff8e5b65aa018f9f92577c00aa","createTime":1712826000000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/5cf55803-9ecf-4122-a0c9-b97fe1142ec6.jpg","title":"CMEF 2024","subTitle":"","html":"

\"可能是包含下列内容的图片：1<\/p>","title4model1":"","html4model1":"

\"可能是包含下列内容的图片：1<\/strong>
<\/p>","expand1":"April 11-14, 2024","expand2":"National Exhibition and Convention Center, Shanghai, China"},{"id":"2c923cff8e5b65aa018f9f8feeb500a9","createTime":1706518800000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/9a372a28-a51f-4d23-af1f-876c069fdebe.jpg","title":"Arab Health 2024","subTitle":"","html":"

\"没有照片描述。\"/<\/p>","title4model1":"","html4model1":"

\"没有照片描述。\"/<\/p>","expand1":"January 29 - February 1, 2024","expand2":"Dubai World Trade Center, Dubai, UAE"},{"id":"2c923cff802bcae8018bfaf9e9084303","createTime":1700722800000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/ac283ada-bbb8-42a0-916b-4267b15eca7f.jpg","title":"ZDRAVO OKHRANENIVE 2023","subTitle":"Booth 23B50","html":"

\n \n<\/p>","title4model1":"","html4model1":"

\n \n<\/p>","expand1":"December 4-8, 2023","expand2":"Moscow, Russia"},{"id":"2c923cff802bcae8018bf5ffdeca4300","createTime":1700640000000,"updateTime":1700639617000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/60ca45c3-e660-479b-bbd3-3205989312ff.jpg","title":"Medcaptain Wins Gold Prize for Best Visual Identity at Transform Awards Asia 2023","subTitle":"","html":"

\n The Transform Awards Asia 2023, organised by Transform Magazine, the world's leading magazine focusing on brand development and rebranding, was held in Shanghai on 20 November 2023 to celebrate the transformative power of rebranding. Medcaptain won the Gold Award for Best visual identity from the healthcare and pharmaceutical sector, securing prestigious recognition for exceptional brand identity and design.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
\n<\/p>\n

\n To support the company's strategy of business diversification and global market expansion, Medcaptain launched a comprehensive brand refresh in February of this year. The new brand slogan, "moments to care," represents Medcaptain's passion and unwavering determination to move forward in the medical and healthcare field steadily, continuously and rapidly.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n The new logo is inspired by the concept of "Captain", wherein two oblique strokes of the letter "M" resemble raised sails, forming a pair of ships sailing together beside a purple trapezoidal pattern below. This pattern signifies Medcaptain's unyielding commitment to innovation and progress in the medical device sector, conveying a long-term vision for moving forward shoulder-to-shoulder with customers and partners.<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n The logo, with its distinctive blend of "progressive purple" and "deep black", emphasises Medcaptain's dynamic, innovative and proficient brand image.<\/span>
\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n The accolade is both an honour and a motivation for Medcaptain, which will inspire Medcaptain to persevere in the pursuit of excellence and advance towards the vision -" To be captain in the medical device industry", bringing more pioneering products and services to clinics and patients.<\/span>\n<\/p>","title4model1":"","html4model1":"

The Transform Awards Asia 2023, organised by Transform Magazine, the world's leading magazine focusing on brand development and rebranding, was held in Shanghai on 20 November 2023 to celebrate the transformative power of rebranding. Medcaptain won the Gold Award for Best visual identity from the healthcare and pharmaceutical sector, securing prestigious recognition for exceptional brand identity and design.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

To support the company's strategy of business diversification and global market expansion, Medcaptain launched a comprehensive brand refresh in February of this year. The new brand slogan, "moments to care," represents Medcaptain's passion and unwavering determination to move forward in the medical and healthcare field steadily, continuously and rapidly.<\/span><\/p>


<\/span><\/p>

The new logo is inspired by the concept of "Captain", wherein two oblique strokes of the letter "M" resemble raised sails, forming a pair of ships sailing together beside a purple trapezoidal pattern below. This pattern signifies Medcaptain's unyielding commitment to innovation and progress in the medical device sector, conveying a long-term vision for moving forward shoulder-to-shoulder with customers and partners.<\/span><\/p>

<\/span><\/p>

The logo, with its distinctive blend of "progressive purple" and "deep black", emphasises Medcaptain's dynamic, innovative and proficient brand image.<\/span>
<\/p>


<\/span><\/p>

The accolade is both an honour and a motivation for Medcaptain, which will inspire Medcaptain to persevere in the pursuit of excellence and advance towards the vision -" To be captain in the medical device industry", bringing more pioneering products and services to clinics and patients.<\/span><\/p>"},{"id":"2c923cff802bcae8018bd704146342f1","createTime":1700042400000,"updateTime":1700119529000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/cc6cab34-762e-4d51-90e7-5b2fcdd7a086.jpg","title":"Medcaptain Dazzles with Innovation at MEDICA 2023","subTitle":"A striking appearance with comprehensive solutions","html":"

\n At MEDICA 2023, an event that attracts the attention of the global medical technology sector, Medcaptain once again made a strong appearance with its outstanding innovations and comprehensive solutions.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n Medcaptain displayed new products in each of its five business areas at the exhibition, demonstrating its strong research and innovation power.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n In the field of Medication Delivery, Medcaptain's new generation of Ambulatory Infusion solutions, HP-80 MRI workstations, iCMS, TCI syringe pumps and other star products are on display to meet the needs of more diversified clinical scenarios.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n Vedkang's complete ESD and ERCP solutions are widely recognised in the industry for their accuracy and reliability. In addition, the VedVision Peroral Cholangioscope Direct Visualization System also attracted many experts and industry professionals who stopped by for inquiries.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n Medcaptain's high-end anaesthesia machine, disposable electronic bronchoscope Solution and VC Series Spirometers, combined with the Penlon series anaesthesia systems, video laryngoscope, monitors and other innovative products, provide safer and more efficient anaesthesia and respiratory solutions, further highlighting Medcaptain's comprehensive strength in the field of critical care.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n In addition, a number of blockbuster in-vitro diagnostics products also receive significant attention. Innovative solutions such as immunoassay, thromboelastography, blood grouping and molecular diagnostics are very popular.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n The four categories of high-value medical disposables - dedication delivery, enteral feeding, airway and respiratory, and interventional cardiology - <\/span>have gained a lot of attention for high quality.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

At MEDICA 2023, an event that attracts the attention of the global medical technology sector, Medcaptain once again made a strong appearance with its outstanding innovations and comprehensive solutions.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

Medcaptain displayed new products in each of its five business areas at the exhibition, demonstrating its strong research and innovation power.<\/span><\/p>

 <\/span><\/p>

In the field of Medication Delivery, Medcaptain's new generation of Ambulatory Infusion solutions, HP-80 MRI workstations, iCMS, TCI syringe pumps and other star products are on display to meet the needs of more diversified clinical scenarios.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

Vedkang's complete ESD and ERCP solutions are widely recognised in the industry for their accuracy and reliability. In addition, the VedVision Peroral Cholangioscope Direct Visualization System also attracted many experts and industry professionals who stopped by for inquiries.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

Medcaptain's high-end anaesthesia machine, disposable electronic bronchoscope Solution and VC Series Spirometers, combined with the Penlon series anaesthesia systems, video laryngoscope, monitors and other innovative products, provide safer and more efficient anaesthesia and respiratory solutions, further highlighting Medcaptain's comprehensive strength in the field of critical care.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

In addition, a number of blockbuster in-vitro diagnostics products also receive significant attention. Innovative solutions such as immunoassay, thromboelastography, blood grouping and molecular diagnostics are very popular.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

The four categories of high-value medical disposables - dedication delivery, enteral feeding, airway and respiratory, and interventional cardiology - <\/span>have gained a lot of attention for high quality.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>"},{"id":"2c923cff802bcae8018acf941e57425d","createTime":1695722400000,"updateTime":1699611847000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/e1fbb9f7-5e6c-47e6-ab4e-08a246f8be7f.gif","title":"MEDICA 2023","subTitle":"","html":"

<\/p>","title4model1":"","html4model1":"

<\/p>","expand1":"November 13-16, 2023","expand2":"Düsseldorf, Germany"},{"id":"2c923cff802bcae8018994efefb341ce","createTime":1690365600000,"updateTime":1690420949000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/0fbfaff7-d279-48c0-ae22-8f550cdb37a0.png","title":"Medcaptain Presents Comprehensive Innovative Technologies at 2023 AACC","subTitle":"","html":"

\n From July 25-27, 2023 AACC Annual Scientific Meeting and Clinical Laboratory Exposition (2023 AACC) is taking place in Anaheim, California. At the world's premier gathering for laboratory medicine, Medcaptain showcased a full series of innovative in-vitro diagnostic products and multi-scenario solutions.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
\n<\/p>\n

\n First held in 1949, AACC Annual Scientific Meeting and Clinical Laboratory Exposition is now the largest event in the global clinical testing field, showcasing a large number of the world's latest clinical laboratory testing equipment and in-vitro diagnostic products every year. This year's event attracted more than 20,000 laboratory professionals and more than 800 exhibitors from more than 110 countries and regions to showcase their latest innovations.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n This time, Medcaptain presented a full range of innovative products and solutions, including solutions for chemiluminescence immunoassay, thromboelastography and coagulation testing, blood grouping and molecular diagnostics. What’s more, Medcaptain unveiled two latest devices to overseas customers, which are Immu F200 Automated Chemiluminescence Immunoassay System and BT-30 Fully Automated Blood Grouping System. The IVD solutions of Medcaptain not only meet the various needs of clinical laboratories, but also further enhance the quality and efficiency of the healthcare industry.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
\n<\/p>\n

\n Medcaptain Immu F200 Fully-automated Chemiluminescence Immunoassay System, as a benchtop chemiluminescence assay disruptor, has a compact design, provides intelligent management and comprehensive laboratory tests. Like the Immu F6 Automated Chemiluminescence Immunoassay System, Immu F200 is an acridinium ester direct chemiluminescent assay system, which will provide small and medium-sized laboratories with a more comprehensive and accurate immunoassay.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n The BT-30 Fully Automated Blood Grouping System is a new member of Medcaptain's one-stop blood grouping solution. It is compatible with gel cards, and is able to perform fast and accurate blood compatibility testing for safe blood transfusion.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n Thromboelastography and coagulation testing is another highlight of Medcaptain's IVD portfolio, including the Haema TX Fully-automated Haemostasis System, traditional coagulation reagents, and new thrombosis markers based on the chemiluminescence platform. It has become an indispensable tool for clinical laboratories as it can help clinical users have a more comprehensive understanding of coagulation status.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n In the field of molecular diagnostics, Medcaptain provides state-of-the-art equipment and testing solutions, including the GeneX-i series of Automatic Digital PCR Analyzer and the GeneX E6 Automated Nucleic Acid Extractor, as well as dozens of molecular assays approved and marketed internationally, to provide more accurate, reliable and rapid diagnostic results for doctors and patients.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
\n<\/p>\n

\n Medcaptain is committed to developing advanced healthcare technologies and solutions that improve the accessibility and efficiency of healthcare services. Through continuous innovation and optimisation, Medcaptain's solutions have been widely applied worldwide. In the future, Medcaptain will continue to strive to push the boundaries of innovation and bring more innovative and practical solutions to the field of clinical laboratory and diagnostic medicine.<\/span>\n<\/p>","title4model1":"","html4model1":"

From July 25-27, 2023 AACC Annual Scientific Meeting and Clinical Laboratory Exposition (2023 AACC) is taking place in Anaheim, California. At the world's premier gathering for laboratory medicine, Medcaptain showcased a full series of innovative in-vitro diagnostic products and multi-scenario solutions.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

First held in 1949, AACC Annual Scientific Meeting and Clinical Laboratory Exposition is now the largest event in the global clinical testing field, showcasing a large number of the world's latest clinical laboratory testing equipment and in-vitro diagnostic products every year. This year's event attracted more than 20,000 laboratory professionals and more than 800 exhibitors from more than 110 countries and regions to showcase their latest innovations.<\/span><\/p>

 <\/span><\/p>

This time, Medcaptain presented a full range of innovative products and solutions, including solutions for chemiluminescence immunoassay, thromboelastography and coagulation testing, blood grouping and molecular diagnostics. What’s more, Medcaptain unveiled two latest devices to overseas customers, which are Immu F200 Automated Chemiluminescence Immunoassay System and BT-30 Fully Automated Blood Grouping System. The IVD solutions of Medcaptain not only meet the various needs of clinical laboratories, but also further enhance the quality and efficiency of the healthcare industry.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

Medcaptain Immu F200 Fully-automated Chemiluminescence Immunoassay System, as a benchtop chemiluminescence assay disruptor, has a compact design, provides intelligent management and comprehensive laboratory tests. Like the Immu F6 Automated Chemiluminescence Immunoassay System, Immu F200 is an acridinium ester direct chemiluminescent assay system, which will provide small and medium-sized laboratories with a more comprehensive and accurate immunoassay.<\/span><\/p>

 <\/span><\/p>

The BT-30 Fully Automated Blood Grouping System is a new member of Medcaptain's one-stop blood grouping solution. It is compatible with gel cards, and is able to perform fast and accurate blood compatibility testing for safe blood transfusion.<\/span><\/p>

 <\/span><\/p>

Thromboelastography and coagulation testing is another highlight of Medcaptain's IVD portfolio, including the Haema TX Fully-automated Haemostasis System, traditional coagulation reagents, and new thrombosis markers based on the chemiluminescence platform. It has become an indispensable tool for clinical laboratories as it can help clinical users have a more comprehensive understanding of coagulation status.<\/span><\/p>

 <\/span><\/p>

In the field of molecular diagnostics, Medcaptain provides state-of-the-art equipment and testing solutions, including the GeneX-i series of Automatic Digital PCR Analyzer and the GeneX E6 Automated Nucleic Acid Extractor, as well as dozens of molecular assays approved and marketed internationally, to provide more accurate, reliable and rapid diagnostic results for doctors and patients.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

Medcaptain is committed to developing advanced healthcare technologies and solutions that improve the accessibility and efficiency of healthcare services. Through continuous innovation and optimisation, Medcaptain's solutions have been widely applied worldwide. In the future, Medcaptain will continue to strive to push the boundaries of innovation and bring more innovative and practical solutions to the field of clinical laboratory and diagnostic medicine.<\/span><\/p>"},{"id":"2c923cff802bcae8018856e052654119","createTime":1685008800000,"updateTime":1685084835000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/0757afef-86fd-425e-8f7d-c0e509d1ec37.jpg","title":"Medcaptain Shines at Hospitalar 2023","subTitle":"Hospitalar 2023 opened on May 23 local time. Medcaptain presented a full range of innovative solutions and was interviewed by local mainstream media, attracting a lot of attention. ","html":"

Hospitalar 2023 opened on May 23 local time. Medcaptain presented a full range of innovative solutions and was interviewed by local mainstream media, attracting a lot of attention.
<\/p>

 <\/span><\/p>

 <\/span><\/p>

Hospitalar: One of the Largest and Most Influential Medical Exhibitions in South America<\/span><\/strong><\/p>

 <\/span><\/p>

After 30 years of deep cultivation in the industry, Hospitalar is not only a bridge of display and business in Latin America, but also an important academic platform for the industry to discuss and share medical development.<\/span><\/p>

 <\/span><\/p>

At this year's event, 1,200+ exhibitors showcased the most recent medical products and equipment and cutting-edge technology to nearly 100,000 visitors from 70 countries and regions around the world.<\/span><\/p>

 <\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

Medcaptain's Full Range of Products on Show<\/span><\/strong><\/p>


<\/span><\/strong><\/p>

Medcaptain showcased its latest technology and product solutions, covering a wide range of medical fields such as medication delivery, minimally invasive interventions, anesthesia and respiratory and in-vitro diagnostics, etc. The HP-80 Infusion Workstation, MS-100 Infusion Workstation, Penlon Prima 460 Anesthesia System, Vedkang VedVision Cholangioscope Direct Visualization System, Immu F6 Automated Chemiluminescence Immunoassay System were among the most notable offerings. These products are highly safe and reliable, meeting the needs of different medical environments and improving the efficiency and quality of patient care.<\/span><\/p>

 <\/span><\/p>

During the exhibition, the Medcaptain booth was packed with professionals and representatives from healthcare organisations stopping by to see and experience the products.<\/span><\/p>

 <\/span><\/p>

 <\/span><\/p>


<\/span><\/p>

Interview from Local Mainstream Media Attention<\/span><\/strong><\/p>


<\/span><\/strong><\/p>

Hospitalar has also witnessed the rapid and steady development of Medcaptain, and during this year's exhibition, the organiser recommended the local media to interview on Medcaptain on site, focusing on the innovative technology that is leading the industry's development and Medcaptain's determination to expand its presence in Brazil so that more people can learn about and experience it.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

In the future, Medcaptain will keep on committing itself to innovative R&D and creation in the medical device field, continuously expand and improve its global marketing network, serve the health needs of all mankind with innovative and quality products, and contribute to the progress of health.<\/span><\/p>","title4model1":"","html4model1":""},{"id":"2c923cff802bcae801884c1533e8410d","createTime":1684904400000,"updateTime":1684903731000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/eefc53ca-21b3-433e-b80f-a8b95dddcc93.jpg","title":"Medcaptain Presents Comprehensive IVD Solutions at WORLDLAB EUROMEDLAB Roma 2023","subTitle":"Medcaptain made an excellent debut at WORLDLAB EUROMEDLAB Roma 2023 by presenting comprehensive innovative solutions for in vitro diagnostics.","html":"

The WORLDLAB-EUROMEDLAB 2023 officially kicked off on 22 May in Rome, Italy.  Medcaptain made an excellent debut by presenting comprehensive innovative solutions for in vitro diagnostics.<\/span><\/p>


<\/span><\/p>


<\/p>

 <\/span><\/p>

Jointly hosted by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the<\/span> Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC), the WORLDLAB-EUROMEDLAB 2023 is a great venue for showcasing the latest technologies and innovations in laboratory medicine. This year, it has attracted more than 5,000 laboratory specialists, clinicians, academics, scientists and researchers from more than 100 countries and regions to discuss and exchange the most recent advancements and emerging trends in the field of clinical medicine laboratories.<\/span><\/span><\/p>

 <\/span><\/p>

At this conference, Medcaptain exhibits the Immu F6 Automated Chemiluminescence Immunoassay System, Haema TX Fully-automated Thromboelastography System, BT-70 Fully Automated Blood Grouping System as well as molecular diagnostic solutions, and has also premiered a number of new assays,<\/span> which garnered a lot of attention from industry professionals.<\/span><\/span><\/p>


<\/span><\/span><\/p>

<\/span><\/span><\/p>

 <\/span><\/p>

Notably, the Immu F6 Automated Chemiluminescence Immunoassay System has been exceptionally perceived by clinical experts for its inventive innovation. Prof. M. Schoorl, R. Kuyper, E. ten Boekel from the Department of Clinical Chemistry, Haematology & Immunology, Northwest Hospital Group, Alkmaar, the Netherlands distributed an examination of the gadget in the web-based display dynamic of WorldLab • EuroMedLab Roma 2023. In this study, the analyzer is capable of performing six tests within 15 minutes in single-use cartridges. The Immu F6 analyzer is suitable for use in the laboratory or in primary and emergency care to exclude e.g. infection or deep vein thrombosis by measuring procalcitonin (PCT) or D-dimers (DDI, respectively. Based on the results of various tests, the analytical performance of procalcitonin (PCT) and D-Dimer (DDI) assays' on the Immu F6 analyzer is satisfactory.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

A wide range of acute and critical care needs are covered by the Medcaptain chemiluminescent immunoassay, including cardiac markers, inflammation markers, and coagulation markers. It works well in the center of chest, emergency, critical care, respiratory, cardiology and many other departments. What’s more, a wide range of tests, including thyroid function, fertility and hormones, and tumour markers, will be available to serve as a solid foundation for clinical diagnosis and treatment.<\/span><\/p>

 <\/span><\/p>

In the future, Medcaptain will continue to put in a lot of effort to satisfy clinical needs and provide more and better products and services to the clinical community in the future with its high level of expertise in in-vitro diagnostics and more cutting-edge technologies!<\/span><\/p>


<\/p>","title4model1":"","html4model1":"

The WORLDLAB-EUROMEDLAB 2023 officially kicked off on 22 May in Rome, Italy.  Medcaptain made an excellent debut by presenting comprehensive innovative solutions for in vitro diagnostics.<\/span><\/p>


<\/span><\/p>


<\/p>

 <\/span><\/p>

Jointly hosted by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the<\/span> Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC), the WORLDLAB-EUROMEDLAB 2023 is a great venue for showcasing the latest technologies and innovations in laboratory medicine. This year, it has attracted more than 5,000 laboratory specialists, clinicians, academics, scientists and researchers from more than 100 countries and regions to discuss and exchange the most recent advancements and emerging trends in the field of clinical medicine laboratories.<\/span><\/span><\/p>

 <\/span><\/p>

At this conference, Medcaptain exhibits the Immu F6 Automated Chemiluminescence Immunoassay System, Haema TX Fully-automated Thromboelastography System, BT-70 Fully Automated Blood Grouping System as well as molecular diagnostic solutions, and has also premiered a number of new assays,<\/span> which garnered a lot of attention from industry professionals.<\/span><\/span><\/p>


<\/span><\/span><\/p>

<\/span><\/span><\/p>

 <\/span><\/p>

Notably, the Immu F6 Automated Chemiluminescence Immunoassay System has been exceptionally perceived by clinical experts for its inventive innovation. Prof. M. Schoorl, R. Kuyper, E. ten Boekel from the Department of Clinical Chemistry, Haematology & Immunology, Northwest Hospital Group, Alkmaar, the Netherlands distributed an examination of the gadget in the web-based display dynamic of WorldLab • EuroMedLab Roma 2023. In this study, the analyzer is capable of performing six tests within 15 minutes in single-use cartridges. The Immu F6 analyzer is suitable for use in the laboratory or in primary and emergency care to exclude e.g. infection or deep vein thrombosis by measuring procalcitonin (PCT) or D-dimers (DDI, respectively. Based on the results of various tests, the analytical performance of procalcitonin (PCT) and D-Dimer (DDI) assays' on the Immu F6 analyzer is satisfactory.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

 <\/span><\/p>

A wide range of acute and critical care needs are covered by the Medcaptain chemiluminescent immunoassay, including cardiac markers, inflammation markers, and coagulation markers. It works well in the center of chest, emergency, critical care, respiratory, cardiology and many other departments. What’s more, a wide range of tests, including thyroid function, fertility and hormones, and tumour markers, will be available to serve as a solid foundation for clinical diagnosis and treatment.<\/span><\/p>

 <\/span><\/p>

In the future, Medcaptain will continue to put in a lot of effort to satisfy clinical needs and provide more and better products and services to the clinical community in the future with its high level of expertise in in-vitro diagnostics and more cutting-edge technologies!<\/span><\/p>


<\/p>"},{"id":"2c923cff802bcae80187262162234078","createTime":1679652000000,"updateTime":1679972091000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/19cecb18-da7b-4e74-b26d-8838be5c3d0e.jpg","title":"Medcaptain Exhibited at ISICEM 2023 with a New Brand Image","subTitle":"Medcaptain presented its innovative products and solutions across all business lines with a new brand image for the first time, demonstrating its confidence in \"To be captain in the medical device industry.”","html":"

\n \n<\/p>\n

\n Photo Credit: ISICEM Official Twitter<\/span>\n<\/p>\n

\n
\n<\/p>\n

\n The 42nd International Symposium on Intensive Care and Emergency Medicine (ISICEM 2023) was held in Brussels, Belgium on March 21-24, 2023. Medcaptain presented its innovative products and solutions across all business lines with a new brand image for the first time, demonstrating its confidence in "To be captain in the medical device industry.”<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n ISICEM is organized in collaboration with the Department of lntensive Care and Emergency Medicine of Erasme University Hospital, Free University of Brussels, and the Belgian Society of lntensive Care Medicine. Started in 1980, this meeting has become one of the largest in its field, now attracting more than 6200 participants from countries worldwide.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n On February 20, Medcaptain released its new brand image and new slogan - moments to care. At ISICEM, an international exchange platform, Medcaptain showcased the latest innovations together with a new brand image, including:<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n The leading Medication Delivery solutions such as MS-100 Infusion Workstation and HP-80 MRI Infusion Workstation; professional In-Vitro Diagnostics solutions such as Immu F6 Automated Chemiluminescence Immunoassay System and comprehensive test items as well as Haema TX Fully-automated Haemostasis System; and one-stop critical care nutrition solutions. In addition, Medcaptain also joined hands with its subsidiary Penlon, a world-renowned anesthesia brand, to showcase high-end Anesthesia and Respiratory solutions, including the Penlon Prima 445 anesthetic machine, VS-10 Series Video Laryngoscope, VC-10/20/30 Series Spirometer and C5 Series Oxygen Concentrator.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n \n<\/p>\n

\n
<\/span>\n<\/p>\n

\n The refreshed booth design, innovative technology, excellent product design and performance helped Medcaptain attract experts and customers from all over the world. <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n The new brand image shows Medcaptain’s continued commitment to serving customers worldwide and driving the development of the healthcare industry. As an important part of the healthcare sector, we will also continue to drive further improvements in healthcare standards and efficiency worldwide.<\/span>\n<\/p>","title4model1":"","html4model1":"

<\/p>

Photo Credit: ISICEM Official Twitter<\/span><\/p>


<\/p>

The 42nd International Symposium on Intensive Care and Emergency Medicine (ISICEM 2023) was held in Brussels, Belgium on March 21-24, 2023. Medcaptain presented its innovative products and solutions across all business lines with a new brand image for the first time, demonstrating its confidence in "To be captain in the medical device industry.”<\/span><\/p>

 <\/span><\/p>

ISICEM is organized in collaboration with the Department of lntensive Care and Emergency Medicine of Erasme University Hospital, Free University of Brussels, and the Belgian Society of lntensive Care Medicine. Started in 1980, this meeting has become one of the largest in its field, now attracting more than 6200 participants from countries worldwide.<\/span><\/p>

 <\/span><\/p>

On February 20, Medcaptain released its new brand image and new slogan - moments to care. At ISICEM, an international exchange platform, Medcaptain showcased the latest innovations together with a new brand image, including:<\/span><\/p>

 <\/span><\/p>

The leading Medication Delivery solutions such as MS-100 Infusion Workstation and HP-80 MRI Infusion Workstation; professional In-Vitro Diagnostics solutions such as Immu F6 Automated Chemiluminescence Immunoassay System and comprehensive test items as well as Haema TX Fully-automated Haemostasis System; and one-stop critical care nutrition solutions. In addition, Medcaptain also joined hands with its subsidiary Penlon, a world-renowned anesthesia brand, to showcase high-end Anesthesia and Respiratory solutions, including the Penlon Prima 445 anesthetic machine, VS-10 Series Video Laryngoscope, VC-10/20/30 Series Spirometer and C5 Series Oxygen Concentrator.<\/span><\/p>

 <\/span><\/p>

<\/p>


<\/span><\/p>

The refreshed booth design, innovative technology, excellent product design and performance helped Medcaptain attract experts and customers from all over the world. <\/span><\/p>

 <\/span><\/p>

<\/span><\/p>


<\/span><\/p>

The new brand image shows Medcaptain’s continued commitment to serving customers worldwide and driving the development of the healthcare industry. As an important part of the healthcare sector, we will also continue to drive further improvements in healthcare standards and efficiency worldwide.<\/span><\/p>"},{"id":"2c923cff802bcae801866e3d37eb3f5c","createTime":1676887200000,"updateTime":1677469786000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/2b7c7354-615b-4a58-aa3c-4c007989bb3b.jpg","title":"Medcaptain unveils new corporate brand logo and slogan - moments to care","subTitle":"Together with a new brand slogan, Medcaptain officially released its new brand worldwide.","html":"

Together with a new brand slogan, “moments to care”, Medcaptain officially released its new brand worldwide on February 20th, revealing its brand ambition with a more innovative and enterprising image. The release of the new brand is a positive step of Medcaptain for further developing its global business development.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

Over the past 10 years, Medcaptain has been committed to providing comprehensive solutions in the area of emergency care and severe diseases, having established the influence of Medcaptain in the application areas of critical care, anesthesia, emergency treatment, diagnosis, and blood transfusion, amongst others. For consecutive years, the multi-channel HP-80 Infusion Workstation has ranked first among China’s recently established technological capabilities, which is now extensively used in thousands of high-end teaching hospitals and medical institutions around the world. Furthermore, the HP-80 MRI Infusion Workstation and MS-100 Infusion Workstation have established Medcaptain’s dominant position in the area of medication delivery with innovative technology.<\/span><\/p>

<\/span><\/p>

In the field of in-vitro diagnostics, Medcaptain has actively expanded its business in the segments of coagulation, immunology, blood transfusion and molecular diagnosis, etc., forming a multi-technology platform ranging from point-of-care testing to professional laboratory facilities. In January of 2022, Medcaptain acquired full ownership of Penlon, a world-renowned anesthesiology and respiratory equipment brand with a history of nearly 80 years. Consequently, Medcaptain has substantially enhanced its competence in the areas of anesthesiology and respiration. <\/span><\/p>


<\/p>

Another of Medcaptain’s strategic acquisitions has been the inclusion of Vedkang, a leading manufacturer of endoscope equipment and consumables, in the Medcaptain Group. Ever since, Medcaptain has expanded the scope of its business activities to include the four core areas of medication delivery, minimally invasive interventions, anesthesia and respiratory, and in-vitro diagnostics. In respect of product application, Medcaptain has also developed rapidly from the initial high-speed development of the departments related to emergency care and severe diseases to the industry leader of integrated solutions for more departments and more scenarios.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

Regarding the launch of the new brand, Ms. Serinna TAN, Branding Director of Medcaptain, commented: "Our products and solutions are going deeper into a wider range of clinical applications; our advantages of technology and market leadership are also being consolidated more extensively in the industry, and the vision of 'To be captain in the medical device industry' has become clearer and firmer. In the future, while rooting from China, Medcaptain will continue to expand its horizons to include the global market, so as to develop the level of medical technology and create greater value for medical professionals with better products, innovation, technology, and high-quality services. The brand’s new mslogan of 'moments to care' represents Medcaptain’s passion and its determination to continuously, steadily and rapidly move forward in the medical and health field."<\/span><\/p>


<\/p>

At present, Medcaptain’s products serve medical institutions at all levels in more than 140 countries around the world. In the course of rapid growth, Medcaptain has developed hand in hand with partners, users, clinical experts and scientific research institutions around the world. Customer needs have always driven and motivated the technological innovations introduced by Medcaptain. It helps Medcaptain establish the image and reality of “high-end products created and manufactured by a high-end brand serving high-end customers” and maintain this image in the eyes of customers across the world. Through the release of the new brand, Medcaptain has once again conveyed the idea of “unshakeable cooperation in the future and joint promotion of the development of the industry” to its partners and customers.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/span><\/p>

For the new brand slogan “moments to care”, Ms. Serinna TAN explained: "Every moment related to health and life is crucial for doctors, patients and families. Innovative medical technology, constantly refined products and clinical solutions are valuable in these important moments, whether at home or hospital. Medcaptain continually innovates, advancing healthcare one step further, so that every moment matters. This is the most important mission and value of the Medcaptain brand. "<\/span><\/p>

<\/span><\/p>

At the same time, Medcaptain has officially released the new logo. Inspired by the brand values of "Captain", the oblique strokes of the letter "M" resemble two raised sails, forming a pair of ships sailing side by side with the purple trapezoidal pattern at the bottom. While revealing Medcaptain’s firm confidence in continuous innovation and progress in the medical device field, this logo pattern also implies Medcaptain’s long-term vision for moving forward hand-in-hand with its customers and partners. With the unique colour combination of “progressive purple” and “deep black”, the logo highlights Medcaptain's brand personality that is progressive, innovative and professional.<\/span><\/p>


<\/p>

<\/span><\/p>


<\/span><\/p>

The new brand slogan and visual identity will be officially applied to the brand touch points of Medcaptain. This is a firm, dynamic, and important step of Medcaptain to implement its long-term goal of unremitting devotion to the development of the medical field, serving customers around the world, and improvement of the overall development of the medical industry.<\/span>
<\/span><\/p>","title4model1":"","html4model1":"

Together with a new brand slogan, “moments to care”, Medcaptain officially released its new brand worldwide on February 20th, revealing its brand ambition with a more innovative and enterprising image. The release of the new brand is a positive step of Medcaptain for further developing its global business development.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

Over the past 10 years, Medcaptain has been committed to providing comprehensive solutions in the area of emergency care and severe diseases, having established the influence of Medcaptain in the application areas of critical care, anesthesia, emergency treatment, diagnosis, and blood transfusion, amongst others. For consecutive years, the multi-channel HP-80 Infusion Workstation has ranked first among China’s recently established technological capabilities, which is now extensively used in thousands of high-end teaching hospitals and medical institutions around the world. Furthermore, the HP-80 MRI Infusion Workstation and MS-100 Infusion Workstation have established Medcaptain’s dominant position in the area of medication delivery with innovative technology.<\/span><\/p>

<\/span><\/p>

In the field of in-vitro diagnostics, Medcaptain has actively expanded its business in the segments of coagulation, immunology, blood transfusion and molecular diagnosis, etc., forming a multi-technology platform ranging from point-of-care testing to professional laboratory facilities. In January of 2022, Medcaptain acquired full ownership of Penlon, a world-renowned anesthesiology and respiratory equipment brand with a history of nearly 80 years. Consequently, Medcaptain has substantially enhanced its competence in the areas of anesthesiology and respiration. <\/span><\/p>


<\/p>

Another of Medcaptain’s strategic acquisitions has been the inclusion of Vedkang, a leading manufacturer of endoscope equipment and consumables, in the Medcaptain Group. Ever since, Medcaptain has expanded the scope of its business activities to include the four core areas of medication delivery, minimally invasive interventions, anesthesia and respiratory, and in-vitro diagnostics. In respect of product application, Medcaptain has also developed rapidly from the initial high-speed development of the departments related to emergency care and severe diseases to the industry leader of integrated solutions for more departments and more scenarios.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

Regarding the launch of the new brand, Ms. Serinna TAN, Branding Director of Medcaptain, commented: "Our products and solutions are going deeper into a wider range of clinical applications; our advantages of technology and market leadership are also being consolidated more extensively in the industry, and the vision of 'To be captain in the medical device industry' has become clearer and firmer. In the future, while rooting from China, Medcaptain will continue to expand its horizons to include the global market, so as to develop the level of medical technology and create greater value for medical professionals with better products, innovation, technology, and high-quality services. The brand’s new slogan of 'moments to care' represents Medcaptain’s passion and its determination to continuously, steadily and rapidly move forward in the medical and health field."<\/span><\/p>


<\/p>

At present, Medcaptain’s products serve medical institutions at all levels in more than 140 countries around the world. In the course of rapid growth, Medcaptain has developed hand in hand with partners, users, clinical experts and scientific research institutions around the world. Customer needs have always driven and motivated the technological innovations introduced by Medcaptain. It helps Medcaptain establish the image and reality of “high-end products created and manufactured by a high-end brand serving high-end customers” and maintain this image in the eyes of customers across the world. Through the release of the new brand, Medcaptain has once again conveyed the idea of “unshakeable cooperation in the future and joint promotion of the development of the industry” to its partners and customers.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/span><\/p>

For the new brand slogan “moments to care”, Ms. Serinna TAN explained: "Every moment related to health and life is crucial for doctors, patients and families. Innovative medical technology, constantly refined products and clinical solutions are valuable in these important moments, whether at home or hospital. Medcaptain continually innovates, advancing healthcare one step further, so that every moment matters. This is the most important mission and value of the Medcaptain brand. "<\/span><\/p>

<\/span><\/p>

At the same time, Medcaptain has officially released the new logo. Inspired by the brand values of "Captain", the oblique strokes of the letter "M" resemble two raised sails, forming a pair of ships sailing side by side with the purple trapezoidal pattern at the bottom. While revealing Medcaptain’s firm confidence in continuous innovation and progress in the medical device field, this logo pattern also implies Medcaptain’s long-term vision for moving forward hand-in-hand with its customers and partners. With the unique colour combination of “progressive purple” and “deep black”, the logo highlights Medcaptain's brand personality that is progressive, innovative and professional.<\/span><\/p>


<\/p>

<\/span><\/p>


<\/span><\/p>

The new brand slogan and visual identity will be officially applied to the brand touch points of Medcaptain. This is a firm, dynamic, and important step of Medcaptain to implement its long-term goal of unremitting devotion to the development of the medical field, serving customers around the world, and improvement of the overall development of the medical industry.<\/span>
<\/span><\/p>"},{"id":"2c923cff802bcae801847aa744d23a37","createTime":1668504600000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/87ae4474-14bc-4229-a006-8f9beef6f678.jpg","title":"Medcaptain Presents Comprehensive Solutions at MEDICA 2022","subTitle":"MEDICA, the world’s largest medical trade fair, opened its doors on November 17, 2022. Medcaptain is taking advantage of this opportunity to introduce a comprehensive range of solutions, among which several much-anticipated new products, to all attendees including clinical and academic experts and industry professionals. ","html":"

\n MEDICA, the world’s largest medical trade fair, opened its doors on November 17, 2022. Medcaptain is taking advantage of this opportunity to introduce a comprehensive range of solutions, among which several much-anticipated new products, to all attendees including clinical and academic experts and industry professionals. <\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
\n<\/p>\n

\n As a global medical device company, Medcaptain places great importance on overseas markets. And MEDICA is a great platform for Medcaptain to introduce its latest innovations and solutions to customers around the world and establish connectivity with them. This year, Medcaptain hosts different stands for different segments.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n Stand 9D31 in Hall 9 is to display its integrated solutions in Medication Delivery, Anaesthesia & Respiratory, In-vitro Diagnostics and Disposables. Highlighted at this stand are the ICU and Operating Room solutions. And Stand 3B58 in Hall 3 focuses on In-vitro Diagnostics. <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
\n<\/p>\n

\n
\n<\/p>\n

\n The visitors gave high praise to the solutions on display and showed great interest in the new products, especially the Spirometer and Ambulatory Infusion Pump. <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n Medcaptain has always been driving innovation and keeps trying to meet the needs of clinical practitioners to develop more comprehensive solutions to help improve clinical efficiency. In the future, Medcaptain will continue to share more medical technologies and provide high-quality healthcare products and solutions for the medical community. <\/span>\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

MEDICA, the world’s largest medical trade fair, opened its doors on November 17, 2022. Medcaptain is taking advantage of this opportunity to introduce a comprehensive range of solutions, among which several much-anticipated new products, to all attendees including clinical and academic experts and industry professionals. <\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

As a global medical device company, Medcaptain places great importance on overseas markets. And MEDICA is a great platform for Medcaptain to introduce its latest innovations and solutions to customers around the world and establish connectivity with them. This year, Medcaptain hosts different stands for different segments.<\/span><\/p>

 <\/span><\/p>

Stand 9D31 in Hall 9 is to display its integrated solutions in Medication Delivery, Anaesthesia & Respiratory, In-vitro Diagnostics and Disposables. Highlighted at this stand are the ICU and Operating Room solutions. And Stand 3B58 in Hall 3 focuses on In-vitro Diagnostics. <\/span><\/p>

 <\/span><\/p>

<\/span><\/p>


<\/p>


<\/p>

The visitors gave high praise to the solutions on display and showed great interest in the new products, especially the Spirometer and Ambulatory Infusion Pump. <\/span><\/p>

 <\/span><\/p>

Medcaptain has always been driving innovation and keeps trying to meet the needs of clinical practitioners to develop more comprehensive solutions to help improve clinical efficiency. In the future, Medcaptain will continue to share more medical technologies and provide high-quality healthcare products and solutions for the medical community. <\/span><\/p>


<\/p>"},{"id":"2c923cff802bcae801840ebeeb4f3608","createTime":1666695600000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/abd99ad6-3025-438c-b900-0fb3e0cb857f.jpg","title":"Medcaptain Exhibits at the 35th ESICM Annual Congress in Paris","subTitle":"The 35th Annual Congress of the European Society of Intensive Care Medicine (ESICM) is held in Paris, France from October 22 to 26. Medcaptain is attending this event in full splendour, bringing comprehensive critical care solutions and innovations to all academic experts and industry professionals present.","html":"

The 35th Annual Congress of the European Society of Intensive Care Medicine (ESICM) is held in Paris, France from October 22 to 26. Medcaptain is attending this event in full splendour, bringing comprehensive critical care solutions and innovations to all academic experts and industry professionals present.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

Originating in 1982, ESICM is a not-for-profit international association with members in over 120 countries and regions worldwide. Since its inception, it has been committed to supporting and promoting the advancement of knowledge in intensive care medicine. ESICM Lives, organised by the association, has become the world's most prestigious international conference in the field of intensive care and one of the most important annual meetings of the global critical care <\/span>community.<\/span><\/p>

 <\/span><\/p>

During the ESICM Lives 2022, Medcaptain showcases its latest innovations in intensive care medicine. At our booth, visitors are introduced to some of Medcaptain’s cutting-edge solutions, which received high attention from the attendees, such as the iCMSTM<\/sup> Infusion Central Monitoring System, MS-100 Infusion Workstation, EP-60 Series Enteral Feeding Pump, HP-80 MRI Infusion Workstation, SYS Series Syringe Pump, KardiFlex® PTCA Balloon Dilatation Catheters, NuFloTM Enteral Feeding Catheters, Tracheal Tubes, Immu F6 Fully Automated Chemiluminescence Immunoassay Analyzer, as well as Haema TX Fully-automated Haemostasis System.<\/span><\/p>

 <\/span><\/p>

As always, Medcaptain is committed to making deeper inroads into the global medical community with leading-edge products and solutions. With an ongoing commitment to innovation and technological advancement, Medcaptain will also continue to forge ahead to further advance healthcare standards and efficiency worldwide.<\/span><\/p>


<\/p>","title4model1":"","html4model1":"

The 35th Annual Congress of the European Society of Intensive Care Medicine (ESICM) is held in Paris, France from October 22 to 26. Medcaptain is attending this event in full splendour, bringing comprehensive critical care solutions and innovations to all academic experts and industry professionals present.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/p>

Originating in 1982, ESICM is a not-for-profit international association with members in over 120 countries and regions worldwide. Since its inception, it has been committed to supporting and promoting the advancement of knowledge in intensive care medicine. ESICM Lives, organised by the association, has become the world's most prestigious international conference in the field of intensive care and one of the most important annual meetings of the global critical care <\/span>community.<\/span><\/p>

 <\/span><\/p>

During the ESICM Lives 2022, Medcaptain showcases its latest innovations in intensive care medicine. At our booth, visitors are introduced to some of Medcaptain’s cutting-edge solutions, which received high attention from the attendees, such as the iCMSTM<\/sup> Infusion Central Monitoring System, MS-100 Infusion Workstation, EP-60 Series Enteral Feeding Pump, HP-80 MRI Infusion Workstation, SYS Series Syringe Pump, KardiFlex® PTCA Balloon Dilatation Catheters, NuFloTM Enteral Feeding Catheters, Tracheal Tubes, Immu F6 Fully Automated Chemiluminescence Immunoassay Analyzer, as well as Haema TX Fully-automated Haemostasis System.<\/span><\/p>

 <\/span><\/p>

As always, Medcaptain is committed to making deeper inroads into the global medical community with leading-edge products and solutions. With an ongoing commitment to innovation and technological advancement, Medcaptain will also continue to forge ahead to further advance healthcare standards and efficiency worldwide.<\/span><\/p>


<\/p>"},{"id":"2c923cff802bcae801830d48fd6424e9","createTime":1662375000000,"updateTime":1662375309000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/463d3efb-dea2-437b-b5e2-866fc977894d.jpg","title":"Medcaptain Presents Its Engagement in Nutrition at ESPEN Congress 2022","subTitle":"At the 44th European Society for Clinical Nutrition and Metabolism (ESPEN) Congress taking place in Vienna on September 3-6, Medcaptain is presenting its comprehensive products in the area of nutrition.","html":"

\n <\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n At the 44th<\/sup> European Society for Clinical Nutrition and Metabolism (ESPEN) Congress taking place in Vienna on September 3-6, Medcaptain is presenting its comprehensive products in the area of nutrition.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n As one of the most influential international academic conferences in the field of nutrition and metabolism, attended by thousands of professionals from all over the world each year, ESPEN Congress provides a platform for doctors, dietitians, pharmacists, nutritionists, nurses, scientists, as well as medical device providers like Medcaptain to discuss and exchange cutting-edge science and promote collaboration and communication. After two years of virtual events, we finally have a chance to meet in person again. This year, the congress is focusing on clinical nutrition diagnosis, treatment and research advances in obesity, ageing, perioperative, gastrointestinal diseases, oncology and critical illness, etc.<\/span>\n<\/p>\n

\n
\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n At ESPEN Congress 2022, Medcaptain is showcasing the integrated enteral feeding system, which provides enteral giving sets, enteral feeding catheters and enteral syringes. What’s more, visitors can also experience the MS-100 infusion workstation, the remotely controlled infusion system, the HP-60 series infusion pump, suitable for blood transfusion, total parenteral nutrition (TPN) therapy and oncology therapy, and the infusion central monitoring system (iCMS), a platform for a variety of applications that make infusion safer, smarter and more efficient. A professional team of consultants is present on-site to address medical questions on the products and solutions. With innovative technology and excellent product design and performance, the Medcaptain booth attracted many experts and industry professionals.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n With an open mind and a far-reaching vision, Medcaptain has always placed a strong focus on the global market. In the future, Medcaptain will accelerate innovation and expand its ability to provide high-value services to the worldwide medical community and make valuable contributions to the development of the medical device industry.<\/span>\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

<\/span><\/p>


<\/span><\/p>

At the 44th<\/sup> European Society for Clinical Nutrition and Metabolism (ESPEN) Congress taking place in Vienna on September 3-6, Medcaptain is presenting its comprehensive products in the area of nutrition.<\/span><\/p>

 <\/span><\/p>

As one of the most influential international academic conferences in the field of nutrition and metabolism, attended by thousands of professionals from all over the world each year, ESPEN Congress provides a platform for doctors, dietitians, pharmacists, nutritionists, nurses, scientists, as well as medical device providers like Medcaptain to discuss and exchange cutting-edge science and promote collaboration and communication. After two years of virtual events, we finally have a chance to meet in person again. This year, the congress is focusing on clinical nutrition diagnosis, treatment and research advances in obesity, ageing, perioperative, gastrointestinal diseases, oncology and critical illness, etc.<\/span><\/p>


<\/p>

<\/span><\/p>


<\/span><\/p>

At ESPEN Congress 2022, Medcaptain is showcasing the integrated enteral feeding system, which provides enteral giving sets, enteral feeding catheters and enteral syringes. What’s more, visitors can also experience the MS-100 infusion workstation, the remotely controlled infusion system, the HP-60 series infusion pump, suitable for blood transfusion, total parenteral nutrition (TPN) therapy and oncology therapy, and the infusion central monitoring system (iCMS), a platform for a variety of applications that make infusion safer, smarter and more efficient. A professional team of consultants is present on-site to address medical questions on the products and solutions. With innovative technology and excellent product design and performance, the Medcaptain booth attracted many experts and industry professionals.<\/span><\/p>

 <\/span><\/p>

With an open mind and a far-reaching vision, Medcaptain has always placed a strong focus on the global market. In the future, Medcaptain will accelerate innovation and expand its ability to provide high-value services to the worldwide medical community and make valuable contributions to the development of the medical device industry.<\/span><\/p>


<\/p>"},{"id":"2c923cff802bcae8018248a466881a26","createTime":1659076200000,"updateTime":1659076227000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/364f1e68-1211-4451-aac7-b2ee72a1df71.jpg","title":"Medcaptain Exhibits at 2022 AACC with Latest In-vitro Diagnostics Innovations","subTitle":"On July 26-28, Medcaptain made a striking appearance with a series of main In-vitro Diagnostics products and solutions at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC), held at the McCormick Place Convention Center in Chicago. ","html":"

\n <\/span>\n<\/p>\n

\n On July 26-28, Medcaptain made a striking appearance with a series of main In-vitro Diagnostics products and solutions at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC), held at the McCormick Place Convention Center in Chicago. <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n Being the world's largest conference of the in-vitro diagnostic industry, the AACC has become one of the most important international academic conferences in the field of clinical testing worldwide and has a significant international influence, attracting over 20,000 international medical professionals and medical device entrepreneurs from over 100 countries worldwide each year.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n At 2022 AACC, Medcaptain showcased the cutting-edge science and technology shaping the future of laboratory medicine, including main products like the Fully-automated Chemiluminescence Immunoassay System, Real-time PCR System, Thromboelastography Analyzer, and Fully Automatic Blood Grouping Analyzer, covering coagulation, chemiluminescence, blood typing and molecular diagnostics, as well as comprehensive test items. It has attracted many visitors from around the world, capturing the much-needed disease testing business opportunities.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n Medcaptain’s latest in-vitro diagnostics innovations enable clinical laboratories greater flexibility and assurance as they respond to new and existing diagnostic challenges. By minimizing hands-on time, reducing time-to-results, and improving analytical performance, Medcaptain, together with clinical users, is working toward improving patient outcomes.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n Over years of operation and development, Medcaptain has won a considerable number of loyal customers in the whole world with its high-quality products and services. In the future, Medcaptain will keep advancing to meet the clinical needs, sharing more medical technologies and providing better healthcare products and solutions for society.<\/span>\n<\/p>","title4model1":"","html4model1":"

<\/span><\/p>

On July 26-28, Medcaptain made a striking appearance with a series of main In-vitro Diagnostics products and solutions at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC), held at the McCormick Place Convention Center in Chicago. <\/span><\/p>

 <\/span><\/p>

<\/span><\/p>


<\/span><\/p>

Being the world's largest conference of the in-vitro diagnostic industry, the AACC has become one of the most important international academic conferences in the field of clinical testing worldwide and has a significant international influence, attracting over 20,000 international medical professionals and medical device entrepreneurs from over 100 countries worldwide each year.<\/span><\/p>

 <\/span><\/p>

At 2022 AACC, Medcaptain showcased the cutting-edge science and technology shaping the future of laboratory medicine, including main products like the Fully-automated Chemiluminescence Immunoassay System, Real-time PCR System, Thromboelastography Analyzer, and Fully Automatic Blood Grouping Analyzer, covering coagulation, chemiluminescence, blood typing and molecular diagnostics, as well as comprehensive test items. It has attracted many visitors from around the world, capturing the much-needed disease testing business opportunities.<\/span><\/p>

 <\/span><\/p>

 <\/span><\/p>


<\/span><\/p>

Medcaptain’s latest in-vitro diagnostics innovations enable clinical laboratories greater flexibility and assurance as they respond to new and existing diagnostic challenges. By minimizing hands-on time, reducing time-to-results, and improving analytical performance, Medcaptain, together with clinical users, is working toward improving patient outcomes.<\/span><\/p>

 <\/span><\/p>

Over years of operation and development, Medcaptain has won a considerable number of loyal customers in the whole world with its high-quality products and services. In the future, Medcaptain will keep advancing to meet the clinical needs, sharing more medical technologies and providing better healthcare products and solutions for society.<\/span><\/p>"},{"id":"2c923cff802bcae80181385c67c1036c","createTime":1654507800000,"updateTime":1654508139000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/a35498e4-5697-46ff-943b-d56df62d3e2b.jpg","title":"Medcaptain & Penlon Shine at Euroanaesthesia 2022","subTitle":"At this year’s Euroanaesthesia congress, Medcaptain and Penlon have taken advantage of the opportunity to introduce some of their latest technologies in the field of anaesthesia and exchange ideas with clinical workers and medical industry practitioners from Europe and all around the world, offering innovative products and solutions to clinical issues.","html":"

\n At this year’s Euroanaesthesia congress, Medcaptain and Penlon have taken advantage of the opportunity to introduce some of their latest technologies in the field of anaesthesia and exchange ideas with clinical workers and medical industry practitioners from Europe and all around the world, offering innovative products and solutions to clinical issues.<\/span>\n<\/p>\n

\n
\n<\/p>\n

\n Taking place from 4 – 6 June 2022 at the Milano Convention Centre in Milan, Italy, Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, the congress is a contemporary event geared towards education, knowledge exchange and innovation in Anaesthesia, Intensive Care, Pain and Perioperative Medicine, as well as a platform for immense international visibility for scientific research.<\/span>\n<\/p>\n

\n
\n<\/p>\n

\n Medcaptain and Penlon exhibited their latest products including MS-100 Infusion Workstation, HP-80 MRI Infusion Workstation and iCMS Infusion Central Monitoring System, Immu F6 Fully-automated Chemiluminescence Immunoassay System and Haema TX Fully-automated Haemostasis System, as well as Penlon’s advanced anaesthesia systems.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n With the innovative technology and excellent product design and performance, the Medcaptain booth attracted many experts and industry professionals. It is worth noting that the product combination of Medcaptain HP-80 MRI Infusion Workstation and Penlon Prima 451 MRI anaesthetic machine has won much attention from the visitors at the scene.<\/span>\n<\/p>\n

\n
\n<\/p>\n

\n With an open mind and a far-reaching vision, Medcaptain has always placed a strong focus on the global market. In the future, Medcaptain will accelerate innovation and expand its ability to provide high-value services to the medical community worldwide and provide valuable contributions to the development of the medical device industry!<\/span>\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

At this year’s Euroanaesthesia congress, Medcaptain and Penlon have taken advantage of the opportunity to introduce some of their latest technologies in the field of anaesthesia and exchange ideas with clinical workers and medical industry practitioners from Europe and all around the world, offering innovative products and solutions to clinical issues.<\/span><\/p>


<\/p>

Taking place from 4 – 6 June 2022 at the Milano Convention Centre in Milan, Italy, Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, the congress is a contemporary event geared towards education, knowledge exchange and innovation in Anaesthesia, Intensive Care, Pain and Perioperative Medicine, as well as a platform for immense international visibility for scientific research.<\/span><\/p>


<\/p>

Medcaptain and Penlon exhibited their latest products including MS-100 Infusion Workstation, HP-80 MRI Infusion Workstation and iCMS Infusion Central Monitoring System, Immu F6 Fully-automated Chemiluminescence Immunoassay System and Haema TX Fully-automated Haemostasis System, as well as Penlon’s advanced anaesthesia systems.<\/span><\/p>

 <\/span><\/p>

<\/span><\/p>


<\/span><\/p>

With the innovative technology and excellent product design and performance, the Medcaptain booth attracted many experts and industry professionals. It is worth noting that the product combination of Medcaptain HP-80 MRI Infusion Workstation and Penlon Prima 451 MRI anaesthetic machine has won much attention from the visitors at the scene.<\/span><\/p>


<\/p>

With an open mind and a far-reaching vision, Medcaptain has always placed a strong focus on the global market. In the future, Medcaptain will accelerate innovation and expand its ability to provide high-value services to the medical community worldwide and provide valuable contributions to the development of the medical device industry!<\/span><\/p>


<\/p>"},{"id":"2c923cff802bcae80180d6c8b126026e","createTime":1652871600000,"updateTime":1652873352000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/777260b0-a6c1-46d3-b5e2-1b030dba92f6.jpg","title":"Medcaptain Showcases Latest Innovations at Hospitalar 2022","subTitle":"From May 17 to 20, Medcaptain is showcasing its latest medical innovations in Medication Delivery, Anesthesia, Airway Management and In-vitro Diagnostics at Hospitalar 2022, the largest and leading medical trade show in Latin America. ","html":"

\n From May 17 to 20, Medcaptain is showcasing its latest medical innovations in Medication Delivery, Anesthesia, Airway Management and In-vitro Diagnostics at Hospitalar 2022, the largest and leading medical trade show in Latin America.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n Taking place in Brazil, the largest healthcare market in Latin America and the eighth-largest market in the world, Hospitalar 2022 is a multi-sector trade fair, featuring over 1,000 exhibitors and over 90,000 attendees from more than 70 countries. <\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n Over the years, Medcaptain has strived to position itself among the key innovators in the medical device industry and<\/span> has further enhanced its strength in the critical care sector since completing the acquisition of Penlon earlier this year.<\/span>\n<\/p>\n

\n  <\/span>\n<\/p>\n

\n At Hospitalar 2022, Medcaptain, alongside Penlon, introduces the latest innovations to all attendees and has impressed many visitors including industry experts, partners and clinical users at the scene by bringing a comprehensive product portfolio consisting of TCI/PCA Pumps, MRI Compatible Infusion Workstations, Remote Control Systems, Anaesthetic Machines, Automated Chemiluminescence Immunoassay Systems, Automated Blood Grouping Systems, as well as related disposables.<\/span>\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n Deeply involved in Brazil and other countries in the Latin American market for many years, Medcaptain has won the trust of many clinical users with its high-quality products and services. In the future, Medcaptain will keep advancing to meet the clinical needs, sharing more medical technologies and providing better healthcare products and solutions for the region.<\/span>\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

From May 17 to 20, Medcaptain is showcasing its latest medical innovations in Medication Delivery, Anesthesia, Airway Management and In-vitro Diagnostics at Hospitalar 2022, the largest and leading medical trade show in Latin America.<\/span><\/p>


<\/span><\/p>

Taking place in Brazil, the largest healthcare market in Latin America and the eighth-largest market in the world, Hospitalar 2022 is a multi-sector trade fair, featuring over 1,000 exhibitors and over 90,000 attendees from more than 70 countries. <\/span><\/p>

 <\/span><\/p>

Over the years, Medcaptain has strived to position itself among the key innovators in the medical device industry and<\/span> has further enhanced its strength in the critical care sector since completing the acquisition of Penlon earlier this year.<\/span><\/p>

 <\/span><\/p>

At Hospitalar 2022, Medcaptain, alongside Penlon, introduces the latest innovations to all attendees and has impressed many visitors including industry experts, partners and clinical users at the scene by bringing a comprehensive product portfolio consisting of TCI/PCA Pumps, MRI Compatible Infusion Workstations, Remote Control Systems, Anaesthetic Machines, Automated Chemiluminescence Immunoassay Systems, Automated Blood Grouping Systems, as well as related disposables.<\/span><\/p>


<\/p>

<\/p>


<\/p>

Deeply involved in Brazil and other countries in the Latin American market for many years, Medcaptain has won the trust of many clinical users with its high-quality products and services. In the future, Medcaptain will keep advancing to meet the clinical needs, sharing more medical technologies and providing better healthcare products and solutions for the region.<\/span><\/p>


<\/p>"},{"id":"2c923cff802bcae801804ae23c7100c8","createTime":1650524400000,"updateTime":1650529696000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/c7539b17-8a72-4ec0-85cc-7ba3ee8e1dfd.jpg","title":"Medcaptain Hosts Latin America Regional Conference to Provide Better Customer Service","subTitle":"Medcaptain has always attached great importance to customer service, and through frequent training and exchange activities around the world, we help our partners improve their service capabilities and better serve the clinical users. ","html":"

Medcaptain has always attached great importance to customer service, and through frequent training and exchange activities around the world, we help our partners improve their service capabilities and better serve the clinical users. <\/span><\/p>


<\/p>

From April 20 to 22, Medcaptain hosts the Regional Conference Latin America 2022 in Lima, Peru. In close cooperation with our regional partners, we provide training on the new products of Medication Delivery, In-Vitro Diagnostics, Anesthesia & Respiratory and Medical Disposables, as well as marketing strategies and successful case sharing for more than 100 partners from 11 countries in Latin America. What’s more, we have invited several experts from first-class hospitals to share the clinical application of the products.<\/span><\/p>


<\/p>

The main products involved include HP series, iCMS, DoseControl, HP TCI, anesthesia solutions, intensive care solutions, and consumables such as the balloon dilatation catheter.<\/span> <\/p>


<\/span><\/p>

<\/span><\/p>


<\/span><\/p>

The three-day training course emphasizes both theory and practice, introducing to the participants the latest medical technologies and providing them with the knowledge and experience of Medcaptain’s portfolio that they need to support clinicians who use Medcaptain equipment every day to ensure the safe and efficient use of our products and make them feel at ease while using them.<\/span><\/p>


This training course is part of Medcaptain's continuing commitment to the local market. To be close to clinical needs, Medcaptain has established a strong local service network to provide efficient services and more training programmes will take place in the near future in other regions.<\/span><\/p>


<\/p>","title4model1":"","html4model1":"

Medcaptain has always attached great importance to customer service, and through frequent training and exchange activities around the world, we help our partners improve their service capabilities and better serve the clinical users. <\/span><\/p>


<\/p>

From April 20 to 22, Medcaptain hosts the Regional Conference Latin America 2022 in Lima, Peru. In close cooperation with our regional partners, we provide training on the new products of Medication Delivery, In-Vitro Diagnostics, Anesthesia & Respiratory and Medical Disposables, as well as marketing strategies and successful case sharing for more than 100 partners from 11 countries in Latin America. What’s more, we have invited several experts from first-class hospitals to share the clinical application of the products.<\/span><\/p>


<\/p>

The main products involved include HP series, iCMS, DoseControl, HP TCI, anesthesia solutions, intensive care solutions, and consumables such as the balloon dilatation catheter.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/span><\/p>

The three-day training course emphasizes both theory and practice, introducing to the participants the latest medical technologies and providing them with the knowledge and experience of Medcaptain’s portfolio that they need to support clinicians who use Medcaptain equipment every day to ensure the safe and efficient use of our products and make them feel at ease while using them.<\/span><\/p>


This training course is part of Medcaptain's continuing commitment to the local market. To be close to clinical needs, Medcaptain has established a strong local service network to provide efficient services and more training programmes will take place in the near future in other regions.<\/span><\/p>


<\/p>"},{"id":"2c923cff80028784018020954019006f","createTime":1648893600000,"updateTime":1649833541000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/981280a0-e14d-46e1-a07d-0a801ca903bb.jpg","title":"Medcaptain Will Exhibit at EuroMedLab!","subTitle":"As Europe gradually reopens from the epidemic, the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab 2021) will be held in Munich, Germany from April 10th to 14th.","html":"

\n As Europe gradually reopens from the epidemic, <\/span>the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab 2021) will be held in Munich, Germany from April 10th to 14th.<\/strong><\/span>\n<\/p>\n

\n
<\/strong>\n<\/p>\n

\n <\/strong>\n<\/p>\n

\n Source: Euromedlab official website<\/span>\n<\/p>\n

\n <\/strong>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n EuroMedLab is jointly organized by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the German Society for Clinical Chemistry and Laboratory Medicine (DGKL). Held every 2 years, the Congress is an important platform for laboratory medicine experts from around the world to share innovative technologies in laboratory medicine.<\/span>\n<\/p>\n

\n
\n<\/p>\n

\n As one of the most mature regions in the development of laboratory medicine in the world, Europe is home to the world's leading experts and technological concepts in laboratory medicine. At this event, Medcaptain Medical Technology Co., Ltd. (hereinafter referred to as Medcaptain) will present innovative products including the fully-automated chemiluminescence immunoassay system, the new generation of blood grouping system and molecular diagnostic solutions, as well as comprehensive test items. We look forward to welcoming more industry experts and scholars to visit us at booth 265!<\/strong><\/span>\n<\/p>\n

\n
<\/strong><\/span>\n<\/p>\n

\n <\/strong><\/span>\n<\/p>\n

\n Meanwhile, Medcaptain has also been actively involved in promoting academic exchanges between China and abroad. As a global public health emergency, sepsis is of great concern to clinicians and basic researchers due to its high morbidity, mortality and medical costs. During the conference, Medcaptain will also join hands with authoritative experts from China and Europe to hold the International Forum on Sepsis Diagnosis and Treatment, which will provide an academic exchange platform to share clinical treatment protocols and experiences with medical professionals around the world.<\/span>\n<\/p>\n

\n
\n<\/p>\n

\n The forum will be broadcasted online and you are cordially invited to register and join in!<\/span>\n<\/p>\n

\n

\n
\n <\/p>\n<\/section>\n

\n Time: 14:00-16:00 (CET) /20:00-22:00 (Beijing)/9:00-11:00 (São Paulo), April 9th, 2022<\/span><\/strong><\/span>\n<\/p>\n

\n Live platform: Zoom<\/span><\/strong><\/span>\n<\/p>\n

\n
<\/span><\/strong><\/span>\n<\/p>\n

\n <\/span><\/strong><\/span>\n<\/p>\n

\n
<\/span><\/strong><\/span>\n<\/p>\n

\n Dr. Djillali ANNANE<\/span><\/strong><\/span>\n<\/p>\n

\n
\n<\/p>\n

\n • Professor in intensive care medicine<\/span>\n<\/p>\n

\n • Dean of the Faculty of Medicine, University of Paris Saclay-Campus of Versailles<\/span>\n<\/p>\n

\n • Head of the critical care department, Raymond Poincaré University Hospital (AP-HP)<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n \n<\/p>\n

\n Dr. Qingqing Dai<\/span><\/strong><\/span>\n<\/p>\n

\n
\n<\/p>\n

\n • Director, Department of Critical Care Medicine, Obstetrics & Gynecology Hospital of Fudan University<\/span>\n<\/p>\n

\n • MD, Critical Care Medicine<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n Agenda<\/strong><\/strong><\/span>\n<\/p>\n

\n
<\/strong><\/strong>\n<\/p>\n

\n <\/strong><\/strong>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n Scan the QR code to register and attend the conference<\/span>\n<\/p>\n

\n
<\/strong><\/strong>\n<\/p>","title4model1":"","html4model1":"

As Europe gradually reopens from the epidemic, <\/span>the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab 2021) will be held in Munich, Germany from April 10th to 14th.<\/strong>
<\/p>


<\/strong><\/p>

<\/strong><\/p>

Source: Euromedlab official website<\/span><\/p>

<\/strong><\/p>


<\/span><\/p>

EuroMedLab is jointly organized by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the German Society for Clinical Chemistry and Laboratory Medicine (DGKL). Held every 2 years, the Congress is an important platform for laboratory medicine experts from around the world to share innovative technologies in laboratory medicine.<\/span><\/p>


<\/p>

As one of the most mature regions in the development of laboratory medicine in the world, Europe is home to the world's leading experts and technological concepts in laboratory medicine. At this event, Medcaptain Medical Technology Co., Ltd. (hereinafter referred to as Medcaptain) will present innovative products including the fully-automated chemiluminescence immunoassay system, the new generation of blood grouping system and molecular diagnostic solutions, as well as comprehensive test items. We look forward to welcoming more industry experts and scholars to visit us at booth 265!<\/strong><\/span><\/p>


<\/strong><\/span><\/p>

<\/strong><\/span><\/p>

Meanwhile, Medcaptain has also been actively involved in promoting academic exchanges between China and abroad. As a global public health emergency, sepsis is of great concern to clinicians and basic researchers due to its high morbidity, mortality and medical costs. During the conference, Medcaptain will also join hands with authoritative experts from China and Europe to hold the International Forum on Sepsis Diagnosis and Treatment, which will provide an academic exchange platform to share clinical treatment protocols and experiences with medical professionals around the world.<\/span><\/p>


<\/p>

The forum will be broadcasted online and you are cordially invited to register and join in!<\/span><\/p>


<\/p><\/section>

Time: 14:00-16:00 (CET) /20:00-22:00 (Beijing)/9:00-11:00 (São Paulo), April 9th, 2022<\/span><\/strong><\/span><\/p>

Live platform: Zoom<\/span><\/strong><\/span><\/p>


<\/span><\/strong><\/span><\/p>

<\/span><\/strong><\/span><\/p>


<\/span><\/strong><\/span><\/p>

Dr. Djillali ANNANE<\/span><\/strong><\/span><\/p>


<\/p>

• Professor in intensive care medicine<\/span><\/p>

• Dean of the Faculty of Medicine, University of Paris Saclay-Campus of Versailles<\/span><\/p>

• Head of the critical care department, Raymond Poincaré University Hospital (AP-HP)<\/span><\/p>


<\/span><\/p>


<\/span><\/p>

<\/p>

Dr. Qingqing Dai<\/span><\/strong><\/span><\/p>


<\/p>

• Director, Department of Critical Care Medicine, Obstetrics & Gynecology Hospital of Fudan University<\/span><\/p>

• MD, Critical Care Medicine<\/span><\/p>


<\/span><\/p>

Agenda<\/strong><\/strong><\/span><\/p>


<\/strong><\/strong><\/p>

<\/strong><\/strong><\/p>

<\/span><\/p>

Scan the QR code to register and attend the conference<\/span><\/p>


<\/strong><\/strong><\/p>"},{"id":"2c923cff8002878401802235733f008e","createTime":1648027800000,"updateTime":1649841417000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/74d60cf1-1c69-47a5-aa66-8e754cce4ca4.jpg","title":"Medcaptain attends the 41st ISICEM in full splendor","subTitle":"From March 22 to 25, the prestigious 41st International Symposium on Intensive Care and Emergency Medicine (ISICEM 2022) took place in Brussels, Belgium.","html":"

From March 22 to 25, the prestigious 41st International Symposium on Intensive Care and Emergency Medicine (ISICEM 2022) took place in Brussels, Belgium.<\/p>


<\/p>

The ISICEM, jointly organized by the Erasme University Medical Center, the Department of Intensive Care and Emergency Medicine of the Université Libre de Bruxelles (ULB) and the Belgian Society of Intensive Care (SIZ), is held every March and has become one of the most influential academic events in the field of acute and intensive care and has been attracting thousands of doctors, nurses and other specialists in the field of intensive care and emergency medicine from all over the world ever since 1980.<\/p>


<\/p>

<\/p>


<\/p>

In this year’s ISICEM, Medcaptain, once again, participated with innovative products and solutions, such as Immu F6 Automated Chemiluminescence Immunoassay System and corresponding assay portfolio, HP-80 Multi-Channel Infusion Workstation with several patented technologies, MS-100 Infusion Workstation and many more. Innovative technologies and outstanding product design and performance have attracted many experts and customers to stop by and experience our products and solutions. In addition, Medcaptain has joined hands with Nutrego, a renowned European nutrition solution brand, to provide a one-stop solution for critical care nutrition, which has also received a lot of attention from the attendees.<\/p>


<\/p>

<\/p>


<\/p>

On the first day of the conference, Dr. Prof. Jean-Louis Vincent, chairman of ISICEM, was welcomed by Medcaptain at our booth and praised Medcaptain's rapid development, innovative products and professional team in Europe.<\/p>


<\/p>

At present, Medcaptain's products are available in more than 140 countries around the world. After several years of operation and development, the branch office established in the Netherlands has provided and installed Medcaptain’s high-quality products in numerous European medical institutions, including well-known large teaching hospitals. In the future ISICEMs and other important academic exchange platforms, Medcaptain will continue to introduce and demonstrate more innovative technologies and solutions.<\/p>


<\/p>


<\/p>


<\/p>","title4model1":"","html4model1":"

From March 22 to 25, the prestigious 41st International Symposium on Intensive Care and Emergency Medicine (ISICEM 2022) took place in Brussels, Belgium.<\/p>


<\/p>

The ISICEM, jointly organized by the Erasme University Medical Center, the Department of Intensive Care and Emergency Medicine of the Université Libre de Bruxelles (ULB) and the Belgian Society of Intensive Care (SIZ), is held every March and has become one of the most influential academic events in the field of acute and intensive care and has been attracting thousands of doctors, nurses and other specialists in the field of intensive care and emergency medicine from all over the world ever since 1980.<\/p>


<\/p>

<\/p>


<\/p>

In this year’s ISICEM, Medcaptain, once again, participated with innovative products and solutions, such as Immu F6 Automated Chemiluminescence Immunoassay System and corresponding assay portfolio, HP-80 Multi-Channel Infusion Workstation with several patented technologies, MS-100 Infusion Workstation and many more. Innovative technologies and outstanding product design and performance have attracted many experts and customers to stop by and experience our products and solutions. In addition, Medcaptain has joined hands with Nutrego, a renowned European nutrition solution brand, to provide a one-stop solution for critical care nutrition, which has also received a lot of attention from the attendees.<\/p>


<\/p>

<\/p>


<\/p>

On the first day of the conference, Dr. Prof. Jean-Louis Vincent, chairman of ISICEM, was welcomed by Medcaptain at our booth and praised Medcaptain's rapid development, innovative products and professional team in Europe.<\/p>


<\/p>

At present, Medcaptain's products are available in more than 140 countries around the world. After several years of operation and development, the branch office established in the Netherlands has provided and installed Medcaptain’s high-quality products in numerous European medical institutions, including well-known large teaching hospitals. In the future ISICEMs and other important academic exchange platforms, Medcaptain will continue to introduce and demonstrate more innovative technologies and solutions.<\/p>


<\/p>


<\/p>


<\/p>


<\/p>"},{"id":"2c923cff7c92c0d3017edc12e44a041e","createTime":1643332080000,"updateTime":1644369812000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/b4519094-df11-4aff-90ee-3d1c81ad6b01.jpg","title":"Medcaptain makes a striking appearance at the first exhibition of the year – Arab Health 2022!","subTitle":"As a member of the global medical device industry, faced with the severe situation of the global war against the pandemic, Medcaptain is once again stepping forward to share the latest product technologies and ideas with clinical workers and medical industry practitioners in the Middle East and around the world, offering its contribution to the global fight against the pandemic. ","html":"

On January 24, the 47th Arab Health was grandly opened at the Dubai World Trade Centre. As a member of the global medical device industry, faced with the severe situation of the global war against the pandemic, Medcaptain is once again stepping forward to share the latest product technologies and ideas with clinical workers and medical industry practitioners in the Middle East and around the world, offering its contribution to the global fight against the pandemic.<\/p>


<\/p>

<\/p>


<\/p>

Arab Health is the largest medical equipment exhibition in the Middle East, with a wide variety of exhibitors and profound influence in the industry. Since it was first held in 1975, the scale of the exhibition has expanded year by year, attracting medical industry practitioners from all over the world. Even with the impact of the global pandemic taken into consideration, this year’s exhibition still attracts more than 3,500 exhibitors and 50,000 healthcare professionals from around the world.<\/p>


<\/p>

In the exhibition, Medcaptain has made a striking appearance with its latest products and solutions, sharing and exchanging cutting-edge technologies and ideas with industry practitioners from all over the world.<\/p>


<\/p>

<\/p>


<\/p>

It is worth noting that in this year’s exhibition, Medcaptain and Nutrego, a well-known global brand in the field of nutrition, have entered into strategic cooperation, joining forces to launch a complete nutrition solution that will include enteral and parenteral nutrition. Nutrego's nutritional products provide nutritional support for oncology patients, surgical patients, and people with diabetes, chronic kidney disease, and swallowing disorders.<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

In this year's first exhibition, Medcaptain has blossomed with new potential in Dubai, serving global clinical users with high-quality innovative solutions. On its mission against the pandemic, this year, Medcaptain will lay out a perfected global marketing network system in order to enable its innovative technologies and high-quality products to reach and benefit even more users!<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>","title4model1":"","html4model1":"

On January 24, the 47th Arab Health was grandly opened at the Dubai World Trade Centre. As a member of the global medical device industry, faced with the severe situation of the global war against the pandemic, Medcaptain is once again stepping forward to share the latest product technologies and ideas with clinical workers and medical industry practitioners in the Middle East and around the world, offering its contribution to the global fight against the pandemic.
<\/p>


<\/p>

<\/p>


<\/p>

Arab Health is the largest medical equipment exhibition in the Middle East, with a wide variety of exhibitors and profound influence in the industry. Since it was first held in 1975, the scale of the exhibition has expanded year by year, attracting medical industry practitioners from all over the world. Even with the impact of the global pandemic taken into consideration, this year’s exhibition still attracts more than 3,500 exhibitors and 50,000 healthcare professionals from around the world.<\/p>


<\/p>

In the exhibition, Medcaptain has made a striking appearance with its latest products and solutions, sharing and exchanging cutting-edge technologies and ideas with industry practitioners from all over the world.<\/p>


<\/p>

<\/p>


<\/p>

It is worth noting that in this year’s exhibition, Medcaptain and Nutrego, a well-known global brand in the field of nutrition, have entered into strategic cooperation, joining forces to launch a complete nutrition solution that will include enteral and parenteral nutrition. Nutrego's nutritional products provide nutritional support for oncology patients, surgical patients, and people with diabetes, chronic kidney disease, and swallowing disorders.<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

In this year's first exhibition, Medcaptain has blossomed with new potential in Dubai, serving global clinical users with high-quality innovative solutions. On its mission against the pandemic, this year, Medcaptain will lay out a perfected global marketing network system in order to enable its innovative technologies and high-quality products to reach and benefit even more users!<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>"},{"id":"2c923cff7c92c0d3017e8b13203a03c1","createTime":1643008200000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/70b63b82-7668-4ce2-b5e5-f86468624e92.png","title":"Medcaptain completes acquisition of Penlon, strengthening its position as a perioperative solutions provider","subTitle":"Shenzhen, China, January 24, 2022: Medcaptain Medical Technology and Penlon, a world-renowned medical device manufacturer, formally entered into an acquisition. As the first step in Medcaptain’s international M&A strategy, this acquisition is set to further strengthen Medcaptain’s position as a perioperative solution provider worldwide. ","html":"

Shenzhen, China, January 24, 2022<\/strong>: Medcaptain Medical Technology and Penlon, a world-renowned medical device manufacturer, formally entered into an acquisition. As the first step in Medcaptain’s international M&A strategy, this acquisition is set to further strengthen Medcaptain’s position as a perioperative solution provider worldwide.<\/p>

 <\/p>

In accordance with the agreement reached between the two parties, the acquisition will consolidate Penlon’s entire business line with Medcaptain’s current business. Through this, Medcaptain has officially taken an important step in laying out its business portfolio in Medication Delivery, In-Vitro Diagnostics, Anesthesia, Respiratory, and Medical Disposables.<\/p>


<\/p>

Penlon: a globally recognized brand with 80 years of dedicated experience<\/strong><\/span><\/p>


<\/p>

Penlon, a long-established medical device company, was founded in Oxford, England in 1943. Its business encompasses primarily manufacturing and sales of products and systems in the fields of anesthesia, intubation and suction & oxygen therapy, with products being exported to more than 90 countries across Europe, North America, the Middle East and Asia.<\/p>


<\/p>

<\/p>


<\/p>

Penlon's anesthesia solutions have proven to be convenient and easy to use, which allows clinicians to focus on the more important aspects of patient safety and health. Meanwhile, being a global leader in the fields of anesthesia and respiratory care, Penlon has mastered the core technologies for manufacturing key components of anesthesia and respiratory products and provides the supply of evaporation tanks to many of the world's leading anesthesia machine brands.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

“With a long history of growth and outstanding innovations and with an ever-improving product portfolio in the fields of anesthesia and respiratory care, Penlon is recognized as the global leader and veteran in these fields, providing vital life support to critically ill patients. The Medcaptain-Penlon combination will enhance our capabilities to provide comprehensive solutions to the medical communities,” said Justin Liu, CEO of Medcaptain.<\/p>


<\/p>

Penlon meets Medcaptain: a<\/span> strategic partnership radiates new energy<\/span><\/strong><\/span><\/p>


<\/span><\/strong><\/span><\/p>

With powerful R&D and high management capacities, Medcaptain has experienced rapid growth in recent years and expanded its business portfolio. With a global vision, the company has always been determined to become a captain in the medical device industry.
<\/p>


<\/p>

<\/p>


<\/p>

This acquisition aims to leverage Penlon's well-established product portfolio in the fields of anesthesia and respiratory care to complement Medcaptain’s existing products and give a strong boost to the current business. In the past few years, Medcaptain's high-end intelligent infusion workstation has been widely recognized in the clinical field. A series of products relying on hardcore technologies in the medication delivery field - HP-80 MRI Infusion Workstation, MS-100 Infusion Workstation and HP TCI Series Syringe Pump – have paved the way to a new era of infusion.<\/p>

 <\/p>

In the field of in-vitro diagnostics, Medcaptain continues to evolve and lead the industry with pioneering technologies, and gradually provides complete solutions in the sub-fields such as blood transfusion and coagulation, chemiluminescence and molecular diagnostics. In addition, in the field of deep vein thrombosis prevention, Medcaptain also provides a comprehensive product portfolio and high-quality services.<\/p>

 <\/p>

The strong alliance with Penlon is of great strategic importance for improving Medcaptain’s perioperative solutions and providing better support and services to clinical staff and patients. Through this acquisition, Medcaptain will also further expand its global presence and continue to increase its competitiveness in the critical care field.<\/p>

 <\/p>

Moreover, after the acquisition is completed, Penlon will join hands with Medcaptain’s R&D management team. “With Medcaptain’s strong innovation ability, highly enterprising spirit and dedication to exploration, I believe that the century-old brand will be rejuvenated, and more innovative products will be introduced in China and abroad to further consolidate its leading global position in the fields of anesthesia and respiratory care,” said Guruswamy Krishnamoorthy, CEO of Penlon.<\/p>

 <\/p>

With an open mind and a far-reaching vision, Medcaptain has always placed a strong focus on the global market. In the future, Medcaptain will work together with Penlon to accelerate innovation and ensure steady development through comprehensive and in-depth cooperation, expanding its ability to provide high-value services to the medical community worldwide and providing valuable contributions to the development of the medical device industry!<\/p>


<\/p>

<\/span><\/strong><\/span>
<\/p>


<\/p>

<\/span>
<\/p>


<\/p>


<\/p>","title4model1":"","html4model1":"

Shenzhen, China, January 24, 2022<\/strong>: Medcaptain Medical Technology and Penlon, a world-renowned medical device manufacturer, formally entered into an acquisition. As the first step in Medcaptain’s international M&A strategy, this acquisition is set to further strengthen Medcaptain’s position as a perioperative solution provider worldwide.<\/p>

 <\/p>

In accordance with the agreement reached between the two parties, the acquisition will consolidate Penlon’s entire business line with Medcaptain’s current business. Through this, Medcaptain has officially taken an important step in laying out its business portfolio in Medication Delivery, In-Vitro Diagnostics, Anesthesia, Respiratory, and Medical Disposables.<\/p>


<\/p>

Penlon: a globally recognized brand with 80 years of dedicated experience<\/strong><\/span><\/p>


<\/p>

Penlon, a long-established medical device company, was founded in Oxford, England in 1943. Its business encompasses primarily manufacturing and sales of products and systems in the fields of anesthesia, intubation and suction & oxygen therapy, with products being exported to more than 90 countries across Europe, North America, the Middle East and Asia.<\/p>


<\/p>

<\/p>


<\/p>

Penlon's anesthesia solutions have proven to be convenient and easy to use, which allows clinicians to focus on the more important aspects of patient safety and health. Meanwhile, being a global leader in the fields of anesthesia and respiratory care, Penlon has mastered the core technologies for manufacturing key components of anesthesia and respiratory products and provides the supply of evaporation tanks to many of the world's leading anesthesia machine brands.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

“With a long history of growth and outstanding innovations and with an ever-improving product portfolio in the fields of anesthesia and respiratory care, Penlon is recognized as the global leader and veteran in these fields, providing vital life support to critically ill patients. The Medcaptain-Penlon combination will enhance our capabilities to provide comprehensive solutions to the medical communities,” said Justin Liu, CEO of Medcaptain.<\/p>


<\/p>

Penlon meets Medcaptain: a<\/span> strategic partnership radiates new energy<\/span><\/strong><\/span><\/p>


<\/span><\/strong><\/span><\/p>

With powerful R&D and high management capacities, Medcaptain has experienced rapid growth in recent years and expanded its business portfolio. With a global vision, the company has always been determined to become a captain in the medical device industry.
<\/p>


<\/p>

<\/p>


<\/p>

This acquisition aims to leverage Penlon's well-established product portfolio in the fields of anesthesia and respiratory care to complement Medcaptain’s existing products and give a strong boost to the current business. In the past few years, Medcaptain's high-end intelligent infusion workstation has been widely recognized in the clinical field. A series of products relying on hardcore technologies in the medication delivery field - HP-80 MRI Infusion Workstation, MS-100 Infusion Workstation and HP TCI Series Syringe Pump – have paved the way to a new era of infusion.<\/p>

 <\/p>

In the field of in-vitro diagnostics, Medcaptain continues to evolve and lead the industry with pioneering technologies, and gradually provides complete solutions in the sub-fields such as blood transfusion and coagulation, chemiluminescence and molecular diagnostics. In addition, in the field of deep vein thrombosis prevention, Medcaptain also provides a comprehensive product portfolio and high-quality services.<\/p>

 <\/p>

The strong alliance with Penlon is of great strategic importance for improving Medcaptain’s perioperative solutions and providing better support and services to clinical staff and patients. Through this acquisition, Medcaptain will also further expand its global presence and continue to increase its competitiveness in the critical care field.<\/p>

 <\/p>

Moreover, after the acquisition is completed, Penlon will join hands with Medcaptain’s R&D management team. “With Medcaptain’s strong innovation ability, highly enterprising spirit and dedication to exploration, I believe that the century-old brand will be rejuvenated, and more innovative products will be introduced in China and abroad to further consolidate its leading global position in the fields of anesthesia and respiratory care,” said Guruswamy Krishnamoorthy, CEO of Penlon.<\/p>

 <\/p>

With an open mind and a far-reaching vision, Medcaptain has always placed a strong focus on the global market. In the future, Medcaptain will work together with Penlon to accelerate innovation and ensure steady development through comprehensive and in-depth cooperation, expanding its ability to provide high-value services to the medical community worldwide and providing valuable contributions to the development of the medical device industry!<\/p>


<\/p>

<\/span><\/strong><\/span>
<\/p>


<\/p>

<\/span>
<\/p>


<\/p>


<\/p>


<\/p>"},{"id":"2c923cff7c92c0d3017d8db3c9280304","createTime":1638520200000,"updateTime":1638759983000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/014fefd0-200c-4438-88f7-1480a1a666aa.jpg","title":"Medcaptain has obtained MHRA registration confirmation letter for multiple products in Great Britain!","subTitle":"So far, a number of Medcaptain‘s medication delivery products, Video Laryngoscope and Immu F6 series Automated Chemiluminescence Immunoassay System, SARS-CoV-2 IgG/IgM(GICA) have been registered with the MHRA in Great Britain, which means that these products can now be marketed in Great Britain.","html":"

We are pleased to announce that another 17 chemiluminescence reagents have been registered with the MHRA!<\/p>


<\/p>

<\/p>

So far, a number of Medcaptain‘s medication delivery products, Video Laryngoscope and Immu F6 series Automated Chemiluminescence Immunoassay System, SARS-CoV-2 IgG/IgM(GICA)  have been registered with the MHRA in Great Britain, which means that these products can now be marketed in Great Britain.<\/p>


<\/p>

Among these, the medication delivery products that have been registered with MHRA including HP, MP, SYS series Infusion Pumps and Syringe Pumps, HP and MP Infusion Workstations as well as Enteral Feeding Pumps.<\/p>


<\/p>

<\/p>

HP Series Infusion System<\/span><\/p>

<\/span><\/p>

Immu F6 Automated Chemiluminescence Immunoassay System<\/span><\/p>


<\/p>

Over the years, Medcaptain has always pursued the continuous exploration of innovative technologies and promoted the construction of a quality management system with high standards and strict requirements. Given that a number of our products have now obtained MHRA registration confirmation letter, Medcaptain is given the opportunity to promote innovative cutting-edge technologies and quality services in more regions around the world and benefit even more patients and healthcare professionals.<\/p>

<\/span>
<\/p>


<\/p>","title4model1":"","html4model1":"

We are pleased to announce that another 17 chemiluminescence reagents have been registered with the MHRA!<\/p>


<\/p>

<\/p>

So far, a number of Medcaptain‘s medication delivery products, Video Laryngoscope and Immu F6 series Automated Chemiluminescence Immunoassay System, SARS-CoV-2 IgG/IgM(GICA)  have been registered with the MHRA in Great Britain, which means that these products can now be marketed in Great Britain.<\/p>


<\/p>

Among these, the medication delivery products that have been registered with MHRA including HP, MP, SYS series Infusion Pumps and Syringe Pumps, HP and MP Infusion Workstations as well as Enteral Feeding Pumps.<\/p>


<\/p>

<\/p>

HP Series Infusion System<\/span><\/p>

<\/span><\/p>

Immu F6 Automated Chemiluminescence Immunoassay System<\/span><\/p>


<\/p>

Over the years, Medcaptain has always pursued the continuous exploration of innovative technologies and promoted the construction of a quality management system with high standards and strict requirements. Given that a number of our products have now obtained MHRA registration confirmation letter, Medcaptain is given the opportunity to promote innovative cutting-edge technologies and quality services in more regions around the world and benefit even more patients and healthcare professionals.<\/p>

<\/span>
<\/p>


<\/p>


<\/p>"},{"id":"2c923cff7c92c0d3017d2d99597c02a8","createTime":1637141400000,"updateTime":1637147763000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/805a4b2f-a4b9-4562-a471-99d54988f09a.jpg","title":"Medcaptain exhibits in MEDICA 2021！","subTitle":"Once again, Medcaptain Medical Technology is exhibiting innovative products & solutions at the world's largest trade fair for medical technology – MEDICA. ","html":"

<\/p>


<\/p>

Once again, Medcaptain Medical Technology is exhibiting innovative products & solutions at the world's largest trade fair for medical technology – MEDICA. This year's fair is taking place from the 15th to the 18th of November in Messe Dusseldorf and has gathered over 5600 exhibitors present in 17 halls. <\/p>


<\/p>

At this year's fair, Medcaptain is present at two booths. Among exhibited products are also some of our newest solutions launching in Europe for the first time.
<\/p>


<\/p>

<\/p>


<\/p>

The booth C21 is located in the main hall 9 and this is where visitors are able to experience and learn more about our newest products in the infusion management field such as HP-80 MRI Infusion Workstation and MS-100 Infusion Workstation. A variety of other products such as the VS-10 Video Laryngoscope are also exhibited at this booth. <\/p>


<\/p>

<\/p>


<\/p>

The booth B60 is located in hall 3 and is focusing on our innovative solutions in the field of diagnostics such as BT-70 Fully Automated Blood Bank Analyzer, Immu F6 Automated Chemiluminescence Immunoassay System and Haema TX Fully Automated Haemostasis Analyzer. <\/p>


<\/p>

<\/p>


<\/p>

So far, those who visited our booths have expressed great interest in our products. We are looking forward to welcoming you at both of our booths!<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>","title4model1":"","html4model1":"

<\/p>


<\/p>

Once again, Medcaptain Medical Technology is exhibiting innovative products & solutions at the world's largest trade fair for medical technology – MEDICA. This year's fair is taking place from the 15th to the 18th of November in Messe Dusseldorf and has gathered over 5600 exhibitors present in 17 halls. <\/p>


<\/p>

At this year's fair, Medcaptain is present at two booths. Among exhibited products are also some of our newest solutions launching in Europe for the first time.
<\/p>


<\/p>

<\/p>


<\/p>

The booth C21 is located in the main hall 9 and this is where visitors are able to experience and learn more about our newest products in the infusion management field such as HP-80 MRI Infusion Workstation and MS-100 Infusion Workstation. A variety of other products such as the VS-10 Video Laryngoscope are also exhibited at this booth. <\/p>


<\/p>

<\/p>


<\/p>

The booth B60 is located in hall 3 and is focusing on our innovative solutions in the field of diagnostics such as BT-70 Fully Automated Blood Bank Analyzer, Immu F6 Automated Chemiluminescence Immunoassay System and Haema TX Fully Automated Haemostasis Analyzer. <\/p>


<\/p>

<\/p>


<\/p>

So far, those who visited our booths have expressed great interest in our products. We are looking forward to welcoming you at both of our booths!<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>


<\/p>"},{"id":"2c923cff7c92c0d3017cb604a8580169","createTime":1634119200000,"updateTime":1691983016000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/747b439e-48ac-42b5-b355-c0cf5943ad73.jpg","title":"2021CMEF | Medcaptain Introduces Three Innovative Solutions and Unlocks a New Stage of Smart Healthcare","subTitle":"At the 85th China International Medical Equipment Fair (CMEF), in line with the “Embracing the Future with Smart Healthcare” theme, Medcaptain Medical Technology focused on the innovation and application of cutting-edge technologies and medical services and presented a full range of new products and solutions.","html":"

\n \n<\/p>\n

\n
\n<\/p>\n

\n At the 85th China International Medical Equipment Fair (CMEF), in line with the “Embracing the Future with Smart Healthcare” theme, Medcaptain Medical Technology focused on the innovation and application of cutting-edge technologies and medical services and presented a full range of new products and solutions.\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n On the morning of October 13th, Medcaptain introduced the HP Series Intelligent Infusion Therapy Management Solution at the first new product launch. Mr. Zhao Zilin, Chairman of the China Medical Equipment Association and Chairman of the China Medical Equipment Artificial Intelligence Alliance, visited Medcaptain’s booth and jointly cut the ribbon with Medcaptain, marking the official launch of the HP Series Intelligent Infusion Therapy Management Solution.\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n In the field of medication delivery, Medcaptain has pursued product innovation for many years and effectively solved a series of technical problems faced by the industry by patenting a number of core technologies and with several new products becoming industry leaders.\n<\/p>\n

\n
\n<\/p>\n

\n Blood transfusion, as a special method of modern medical treatment, plays an irreplaceable role in curing diseases and saving lives. As blood transfusion medicine moves towards personalized and precise treatment, the industry also holds numerous development opportunities.\n<\/p>\n

\n
\n<\/p>\n

\n Over the years, Medcaptain has always been on the lookout for clinical pain points and difficulties, and it is in this spirit that Medcaptain is proud to introduce an independently developed, new generation fully automated blood group analysis system - BT-70!\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n In order to meet numerous requirements of the infusion of enteral nutrition processes, such as continuous and intermittent infusion, touch control warming, precise feeding and information management, Medcaptain has created a complete solution built around the infusion management field to provide a convenient, precise and safe infusion of enteral nutrition.\n<\/p>\n

\n
\n<\/p>\n

\n In the afternoon, at the NuFloTM<\/sup> nasogastric tube new product launch, Medcaptain’s product manager introduced the three core advantages of the NuFloTM<\/sup> single-use nasogastric tube which are: freehand direct access, simple & comfortable and safe & clog-proof, by comparing the three traditional methods for nasogastric tube placement, namely a fluoroscopy-guided placement, endoscopy-guided placement and ultrasound-guided placement. This prompted many in the audience to stay for further consultation.\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n \n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n In addition, various other innovative products and solutions were also presented at the exhibition site, attracting a lot of attention.\n<\/p>","title4model1":"","html4model1":"

<\/p>


<\/p>

At the 85th China International Medical Equipment Fair (CMEF), in line with the “Embracing the Future with Smart Healthcare” theme, Medcaptain Medical Technology focused on the innovation and application of cutting-edge technologies and medical services and presented a full range of new products and solutions.<\/p>


<\/p>

<\/p>


<\/p>

On the morning of October 13th, Medcaptain introduced the HP Series Intelligent Infusion Therapy Management Solution at the first new product launch. Mr. Zhao Zilin, Chairman of the China Medical Equipment Association and Chairman of the China Medical Equipment Artificial Intelligence Alliance, visited Medcaptain’s booth and jointly cut the ribbon with Medcaptain, marking the official launch of the HP Series Intelligent Infusion Therapy Management Solution.<\/p>


<\/p>

<\/p>


<\/p>

In the field of medication delivery, Medcaptain has pursued product innovation for many years and effectively solved a series of technical problems faced by the industry by patenting a number of core technologies and with several new products becoming industry leaders.<\/p>


<\/p>

Blood transfusion, as a special method of modern medical treatment, plays an irreplaceable role in curing diseases and saving lives. As blood transfusion medicine moves towards personalized and precise treatment, the industry also holds numerous development opportunities.<\/p>


<\/p>

Over the years, Medcaptain has always been on the lookout for clinical pain points and difficulties, and it is in this spirit that Medcaptain is proud to introduce an independently developed, new generation fully automated blood group analysis system - BT-70!<\/p>


<\/p>

<\/p>


<\/p>

In order to meet numerous requirements of the infusion of enteral nutrition processes, such as continuous and intermittent infusion, touch control warming, precise feeding and information management, Medcaptain has created a complete solution built around the infusion management field to provide a convenient, precise and safe infusion of enteral nutrition.<\/p>


<\/p>

In the afternoon, at the NuFloTM<\/sup> nasogastric tube new product launch, Medcaptain’s product manager introduced the three core advantages of the NuFloTM<\/sup> single-use nasogastric tube which are: freehand direct access, simple & comfortable and safe & clog-proof, by comparing the three traditional methods for nasogastric tube placement, namely a fluoroscopy-guided placement, endoscopy-guided placement and ultrasound-guided placement. This prompted many in the audience to stay for further consultation.<\/p>


<\/p>

<\/p>

<\/p>

<\/p>


<\/p>

In addition, various other innovative products and solutions were also presented at the exhibition site, attracting a lot of attention.<\/p>"},{"id":"2c923cff7a192b5b017bc4978c330288","createTime":1630407600000,"updateTime":1631090915000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/75f38817-8817-4092-80b1-07bb83937a13.jpg","title":"Medcaptain exhibits at the 40th ISICEM in Brussels","subTitle":"The 40th International Symposium on Intensive Care & Emergency Medicine (ISICEM) was held in-person in Brussels, from August 31 to September 3. Originated in 1980, ISICEM has soon become one of the largest symposiums in the field of intensive care & emergency medicine, attracting over 6200 participants from all over the world. ","html":"

\n The 40th International Symposium on Intensive Care & Emergency Medicine (ISICEM) was held in-person in Brussels, from August 31 to September 3. Originated in 1980, ISICEM has soon become one of the largest symposiums in the field of intensive care & emergency medicine, attracting over 6200 participants from all over the world.<\/span> \n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n Over the years, ISICEM has established itself as an independent organization whose aim is to facilitate constructive academic exchanges and improve the care of the critically ill patients. <\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n Medcaptain has also taken part in this year’s ISICEM. At our booth, visitors were introduced to some of Medcaptain’s cutting-edge solutions such as MS-100 Infusion Workstation, HP-80 Infusion Workstation, Haema T4 Haemostasis Analyzer, Haema TX Fully-automated Haemostasis System, Immu F6 Automated Chemiluminescence Immunoassay System, MIRUS TM Controller and so on.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
<\/span>
\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

The 40th International Symposium on Intensive Care & Emergency Medicine (ISICEM) was held in-person in Brussels, from August 31 to September 3. Originated in 1980, ISICEM has soon become one of the largest symposiums in the field of intensive care & emergency medicine, attracting over 6200 participants from all over the world.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

Over the years, ISICEM has established itself as an independent organization whose aim is to facilitate constructive academic exchanges and improve the care of the critically ill patients. <\/span><\/p>


<\/span><\/p>

Medcaptain has also taken part in this year’s ISICEM. At our booth, visitors were introduced to some of Medcaptain’s cutting-edge solutions such as MS-100 Infusion Workstation, HP-80 Infusion Workstation, Haema T4 Haemostasis Analyzer, Haema TX Fully-automated Haemostasis System, Immu F6 Automated Chemiluminescence Immunoassay System, MIRUS TM Controller and so on.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>


<\/span>
<\/p>


<\/p>


<\/p>"},{"id":"2c923cff7a192b5b017aad54c1a600ab","createTime":1626327600000,"updateTime":1630036035000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/46e61b6c-9422-47e4-ae5b-8da5ae540731.jpg","title":"ISTH 2021: Medcaptain's innovative products in the field of coagulation acknowledged by experts!","subTitle":"The 29th Annual Meeting of the International Society on Thrombosis and Haemostasis (ISTH) 2021 will be held in a fully virtual format from July 17-21, 2021. Being the most influential international event in the field of thrombosis and hemostasis, it will attract thousands of the world's leading experts in thrombosis, hemostasis and vascular biology, who will gather to exchange the latest research results and discoveries, discuss the latest clinical applications in the field, and promote comprehensive public understanding about the prevention, diagnosis and treatment of thrombotic and bleeding disorders. ","html":"

The 29th Annual Meeting of the International Society on Thrombosis and Haemostasis (ISTH) 2021 will be held in a fully virtual format from July 17-21, 2021. Being the most influential international event in the field of thrombosis and hemostasis, it will attract thousands of the world's leading experts in thrombosis, hemostasis and vascular biology, who will gather to exchange the latest research results and discoveries, discuss the latest clinical applications in the field, and promote comprehensive public understanding about the prevention, diagnosis and treatment of thrombotic and bleeding disorders.<\/span><\/p>

<\/span><\/p>

Due to its innovative technology in the field of thrombosis and hemostasis, Medcaptain’s Haema T4 Haemostasis System has been endorsed by  Dr. Marianne Schoorl, a consultant from Northwest Clinics Alkmaar KCHI laboratory in the Netherlands. In the ISTH 2021 online annual meeting, Dr. Schoorl introduced her experience with the Haema T4 Haemostasis System to experts in the field of thrombosis and hemostasis from around the world, and praised the excellent performance of this product.<\/span><\/p>

<\/span><\/p>

<\/span><\/p>

Point-of-care whole blood analysis by using “Thromboelastography” technology provides physiological and comprehensive insight into patients’ haemostasis process, so as to guide blood transfusion and medication therapy, identify bleeding or thrombosis risks, etc.<\/span><\/p>


<\/span><\/p>

In the presence of growing clinical demand, fully automated thromboelastography has become the priority direction in industry development. Medcaptain leads the way to the fully automated era of thromboelastography with its groundbreaking technology, and has launched the new generation of fully automatic thromboelastography analyzer Haema TX.<\/span>
<\/p>


<\/span><\/p>

<\/p>


<\/span><\/p>

On that account, Medcaptain will continue to rely on its high level of expertise in the field of in-vitro diagnostics and more innovative technologies to meet outstanding clinical needs, provide even better products and services, and keep pushing forward towards becoming a leader in the medical device industry!<\/span><\/p>


<\/span><\/p>

Article Link: https://abstracts.isth.org/abstract/analytical-performance-of-the-novel-haema-t4-thromboelastograph/<\/strong><\/a>
<\/span><\/p>


<\/span><\/p>

<\/span>
<\/p>

<\/span>
<\/p>

<\/span>
<\/p>


<\/p>","title4model1":"","html4model1":"

The 29th Annual Meeting of the International Society on Thrombosis and Haemostasis (ISTH) 2021 will be held in a fully virtual format from July 17-21, 2021. Being the most influential international event in the field of thrombosis and hemostasis, it will attract thousands of the world's leading experts in thrombosis, hemostasis and vascular biology, who will gather to exchange the latest research results and discoveries, discuss the latest clinical applications in the field, and promote comprehensive public understanding about the prevention, diagnosis and treatment of thrombotic and bleeding disorders.<\/span><\/p>

<\/span><\/p>

Due to its innovative technology in the field of thrombosis and hemostasis, Medcaptain’s Haema T4 Haemostasis System has been endorsed by  Dr. Marianne Schoorl, a consultant from Northwest Clinics Alkmaar KCHI laboratory in the Netherlands. In the ISTH 2021 online annual meeting, Dr. Schoorl introduced her experience with the Haema T4 Haemostasis System to experts in the field of thrombosis and hemostasis from around the world, and praised the excellent performance of this product.<\/span><\/p>

<\/span><\/p>

<\/span><\/p>

Point-of-care whole blood analysis by using “Thromboelastography” technology provides physiological and comprehensive insight into patients’ haemostasis process, so as to guide blood transfusion and medication therapy, identify bleeding or thrombosis risks, etc.<\/span><\/p>


<\/span><\/p>

In the presence of growing clinical demand, fully automated thromboelastography has become the priority direction in industry development. Medcaptain leads the way to the fully automated era of thromboelastography with its groundbreaking technology, and has launched the new generation of fully automatic thromboelastography analyzer Haema TX.<\/span>
<\/p>


<\/span><\/p>

<\/p>


<\/span><\/p>

On that account, Medcaptain will continue to rely on its high level of expertise in the field of in-vitro diagnostics and more innovative technologies to meet outstanding clinical needs, provide even better products and services, and keep pushing forward towards becoming a leader in the medical device industry!<\/span><\/p>


<\/span><\/p>

Article Link: https://abstracts.isth.org/abstract/analytical-performance-of-the-novel-haema-t4-thromboelastograph/<\/strong><\/a>
<\/span><\/p>


<\/span><\/p>

<\/span>
<\/p>

<\/span>
<\/p>

<\/span>
<\/p>


<\/p>


<\/p>"},{"id":"2c923cff780083cb0179120d8b0c01b2","createTime":1619505000000,"updateTime":1619505685000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/af074cf5-5745-4747-a06e-9103fc5679ee.jpg","title":"Medcaptain Wins Two World-Renowned Design Awards : Red Dot Award and iF Design Award !","subTitle":"Recently, the German Red Dot Design Award Committee and the iF Design Award Committee have announced the list of winners for 2021, which included a number of Medcaptain's groundbreaking products. So far, two of the top three “Oscars” of global industrial design have been won by Medcaptain. ","html":"

\n Recently, the German Red Dot Design Award Committee and the iF Design Award Committee have announced the list of winners for 2021, which included a number of Medcaptain's groundbreaking products. So far, two of the top three “Oscars” of global industrial design have been won by Medcaptain.\n<\/p>\n

\n \n<\/p>\n

\n The German Red Dot (Red Dot Design Award), iF Design Award, and the IDEA (The International Design Excellence Award) presented by the Industrial Designers Society of America, are known as the world's three major design awards, highlighting the outstanding design and high-quality experience of the award-winning products, and representing trusted quality. Medcaptain’s HP-80 multi-channel Infusion Workstation, Haema T4 Haemostasis System, and VS-10 Series Video Laryngoscope were selected from nearly 10,000 entries and were unanimously recognized by internationally renowned designers from various fields, making the award a well-deserved honor.\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n HP-80 multi-channel Infusion Workstation<\/strong>\n<\/p>\n

\n  \n<\/p>\n

\n ● Original 3C relay system, allowing seamless clinical infusion\n<\/p>\n

\n ● Modular design, enabling random combinations of pumps and flexible assembling\n<\/p>\n

\n ● Abundant data ports, reliable information transmission\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n Haema T4 Haemostasis System<\/strong>\n<\/p>\n

\n  \n<\/p>\n

\n ● Innovative measurement method, accurate results\n<\/p>\n

\n ● All-in-one design, rapid 4-channel testing, convenient operation\n<\/p>\n

\n ● Suitable for a variety of operating environments, comprehensive application\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n VS-10 Series Video Laryngoscope<\/strong>\n<\/p>\n

\n  \n<\/p>\n

\n ● Smart power management, water- and dustproof, instant anti-fog technology\n<\/p>\n

\n ● Small body, bigger vision, equipped with a multimedia teaching function\n<\/p>\n

\n ● Equipped with five different kinds of disposable blades to meet different intubation needs\n<\/p>\n

\n
\n<\/p>\n

\n Medcaptain’s outstanding product innovation ability stems from the deep understanding of clinical pain points. Medcaptain’s mission is: "Be closer to healthcare needs, innovate medical technologies and provide high-quality services". In the future, Medcaptain will continue to devote itself to product innovation and technology development, adhere to the company's original values, launch more high-quality innovative products and services to meet outstanding clinical needs, and keep moving forward towards becoming a captain in the medical device industry!\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

Recently, the German Red Dot Design Award Committee and the iF Design Award Committee have announced the list of winners for 2021, which included a number of Medcaptain's groundbreaking products. So far, two of the top three “Oscars” of global industrial design have been won by Medcaptain.<\/p>

<\/p>

The German Red Dot (Red Dot Design Award), iF Design Award, and the IDEA (The International Design Excellence Award) presented by the Industrial Designers Society of America, are known as the world's three major design awards, highlighting the outstanding design and high-quality experience of the award-winning products, and representing trusted quality. Medcaptain’s HP-80 multi-channel Infusion Workstation, Haema T4 Haemostasis System, and VS-10 Series Video Laryngoscope were selected from nearly 10,000 entries and were unanimously recognized by internationally renowned designers from various fields, making the award a well-deserved honor.<\/p>


<\/p>

<\/p>


<\/p>

HP-80 multi-channel Infusion Workstation<\/strong><\/p>

 <\/p>

● Original 3C relay system, allowing seamless clinical infusion<\/p>

● Modular design, enabling random combinations of pumps and flexible assembling<\/p>

● Abundant data ports, reliable information transmission<\/p>


<\/p>

<\/p>


<\/p>

Haema T4 Haemostasis System<\/strong><\/p>

 <\/p>

● Innovative measurement method, accurate results<\/p>

● All-in-one design, rapid 4-channel testing, convenient operation<\/p>

● Suitable for a variety of operating environments, comprehensive application<\/p>


<\/p>

<\/p>


<\/p>

VS-10 Series Video Laryngoscope<\/strong><\/p>

 <\/p>

● Smart power management, water- and dustproof, instant anti-fog technology<\/p>

● Small body, bigger vision, equipped with a multimedia teaching function<\/p>

● Equipped with five different kinds of disposable blades to meet different intubation needs<\/p>


<\/p>

Medcaptain’s outstanding product innovation ability stems from the deep understanding of clinical pain points. Medcaptain’s mission is: "Be closer to healthcare needs, innovate medical technologies and provide high-quality services". In the future, Medcaptain will continue to devote itself to product innovation and technology development, adhere to the company's original values, launch more high-quality innovative products and services to meet outstanding clinical needs, and keep moving forward towards becoming a captain in the medical device industry!<\/p>


<\/p>


<\/p>"},{"id":"2c923cff780083cb0178b5d22d740154","createTime":1617352440000,"updateTime":1617958314000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/fcc41b21-0f8c-43d6-b2e0-3809e9acdac5.jpg","title":"The new combination of chemiluminescence + POCT is recognized by experts once again!","subTitle":"On the afternoon of March 28th, in front of the booth N5-T004 at Chongqing International Expo Center, Medcaptain launched a brand-new product - Immu F6 Automated Chemiluminescence Immunoassay Analyzer, which breaks through clinical site limitations and serves as an effective tool for testing at or near the site of patient care.","html":"

\n By means of accurate quantitative analysis of active substances in human serum, chemiluminescence immunoassay (CLIA), an advanced immunodiagnostic technology recognized worldwide, is being widely used in tumor markers testing, diagnosis of infectious diseases, endocrine function assessment, hormone testing, etc. It has also proven to be an important tool for the screening of healthy individuals. Furthermore, it is rapidly replacing techniques such as enzyme-linked immunosorbent assay due to its advantages in terms of sensitivity, high degree of automation and accuracy and has thus become the standard of immunodiagnostic technologies.\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n On the afternoon of March 28th, in front of the booth N5-T004 at Chongqing International Expo Center, Medcaptain launched a brand-new product - Immu F6 Automated Chemiluminescence Immunoassay Analyzer, which breaks through clinical site limitations and serves as an effective tool for testing at or near the site of patient care.\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n Medcaptain's fully automated Chemiluminescence Immunoassay Analyzer Immu F6 is another powerful tool for critical care solutions, suitable for use in chest pain centers, emergency departments, ICUs, laboratory departments, infectious diseases departments and cardiology departments.\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n · <\/span><\/strong>Fast: \n<\/p>\n

\n three-step operation, results obtained in 15 minutes\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n · <\/span><\/strong>Accurate: \n<\/p>\n

\n Patented Magnetic Separation Technology ensures high sensitivity\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n · <\/span><\/strong>Simple: \n<\/p>\n

\n supports whole blood, plasma and serum samples\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n · <\/span><\/strong>Nimble: \n<\/p>\n

\n single-use, individually packaged reagent strips, ready to use, reducing cross-contamination\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n Over the years, Medcaptain has always been looking for clinical difficulties, focused on solving pain points and followed the path of "combining industry, academia, research and medicine". Up to now, Medcaptain's in vitro diagnostic portfolio includes coagulation testing, chemiluminescence, blood transfusion solutions, molecular diagnostics, etc. In the future, Medcaptain will launch more high-quality products and continue to serve the healthcare industry.\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

By means of accurate quantitative analysis of active substances in human serum, chemiluminescence immunoassay (CLIA), an advanced immunodiagnostic technology recognized worldwide, is being widely used in tumor markers testing, diagnosis of infectious diseases, endocrine function assessment, hormone testing, etc. It has also proven to be an important tool for the screening of healthy individuals. Furthermore, it is rapidly replacing techniques such as enzyme-linked immunosorbent assay due to its advantages in terms of sensitivity, high degree of automation and accuracy and has thus become the standard of immunodiagnostic technologies.<\/p>


<\/p>

<\/p>


<\/p>

On the afternoon of March 28th, in front of the booth N5-T004 at Chongqing International Expo Center, Medcaptain launched a brand-new product - Immu F6 Automated Chemiluminescence Immunoassay Analyzer, which breaks through clinical site limitations and serves as an effective tool for testing at or near the site of patient care.<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

Medcaptain's fully automated Chemiluminescence Immunoassay Analyzer Immu F6 is another powerful tool for critical care solutions, suitable for use in chest pain centers, emergency departments, ICUs, laboratory departments, infectious diseases departments and cardiology departments.<\/p>


<\/p>

<\/p>


<\/p>

· <\/span><\/strong>Fast: <\/p>

three-step operation, results obtained in 15 minutes<\/p>


<\/p>

<\/p>


<\/p>

· <\/span><\/strong>Accurate: <\/p>

Patented Magnetic Separation Technology ensures high sensitivity<\/p>


<\/p>

<\/p>


<\/p>

· <\/span><\/strong>Simple: <\/p>

supports whole blood, plasma and serum samples<\/p>


<\/p>

<\/p>


<\/p>

· <\/span><\/strong>Nimble: <\/p>

single-use, individually packaged reagent strips, ready to use, reducing cross-contamination<\/p>


<\/p>

<\/p>


<\/p>

<\/p>


<\/p>

Over the years, Medcaptain has always been looking for clinical difficulties, focused on solving pain points and followed the path of "combining industry, academia, research and medicine". Up to now, Medcaptain's in vitro diagnostic portfolio includes coagulation testing, chemiluminescence, blood transfusion solutions, molecular diagnostics, etc. In the future, Medcaptain will launch more high-quality products and continue to serve the healthcare industry.<\/p>


<\/p>


<\/p>"},{"id":"2c923cff780083cb0179783bb9850234","createTime":1616727600000,"updateTime":1621219902000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/329a398f-e361-4a65-8d61-b54dd5079ff2.jpg","title":"Consular Corps in Guangzhou visit Shenzhen Medcaptain Medical Technology Co., Ltd. and applaud Shenzhen’s innovative power","subTitle":"On March 25, representatives from 41 countries' consulates in Guangzhou and several foreign news organizations in Guangdong paid a two-day visit to Shenzhen.","html":"

\n On March 25, representatives from 41 countries' consulates in Guangzhou and several foreign news organizations in Guangdong paid a two-day visit to Shenzhen. In the afternoon of March 25, they made their first stop at Shenzhen Medcaptain Medical Technology Co., Ltd. to learn about the company’s development and experience the power of independent innovation in Shenzhen.<\/span>\n<\/p>\n

\n
<\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n <\/span>\n<\/p>\n

\n
\n<\/p>\n

\n "Innovation is the hallmark of this great city." Carlos Hilarte, Consul General of Mexico in Guangzhou, praised Shenzhen’s high level of industrialization and rapid technological development. He was impressed by the technology these Shenzhen companies have mastered: "What we saw today is very advanced medical technology and I firmly believe these companies will achieve rapid growth in the medical device industry" At the same time, he was delighted to witness the contribution these companies are making in the fight against the novel coronavirus epidemic in China and abroad.\n<\/p>\n

\n  \n<\/p>\n

\n According to reports, from March 23 Consular Corps in Guangzhou visited Guangzhou, Dongguan, and finally, Shenzhen to experience the major achievements of Guangdong Province during the 13th Five-Year Plan and the 14th Five-Year Plan period and see the future medium and long-term development prospects. They were introduced to the achievements of Guangdong Province in becoming a power source for high-quality development, strengthening intellectual property protection, encouraging independent innovation and development, promoting international cooperation in the fight against epidemics, and jointly building a community with a shared future.\n<\/p>\n

\n
\n<\/p>\n

\n (Part of the material is reproduced from SHENZHEN SPECIAL ZONE DAILY, the original title is "Foreign Consulates in Guangzhou Visiting Shenzhen and Innovation is the Sign of this Great City")<\/span>\n<\/p>\n

\n
<\/span>
\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

On March 25, representatives from 41 countries' consulates in Guangzhou and several foreign news organizations in Guangdong paid a two-day visit to Shenzhen. In the afternoon of March 25, they made their first stop at Shenzhen Medcaptain Medical Technology Co., Ltd. to learn about the company’s development and experience the power of independent innovation in Shenzhen.<\/span><\/p>


<\/span><\/p>

<\/span><\/p>

<\/span><\/p>

<\/span><\/p>


<\/p>

"Innovation is the hallmark of this great city." Carlos Hilarte, Consul General of Mexico in Guangzhou, praised Shenzhen’s high level of industrialization and rapid technological development. He was impressed by the technology these Shenzhen companies have mastered: "What we saw today is very advanced medical technology and I firmly believe these companies will achieve rapid growth in the medical device industry" At the same time, he was delighted to witness the contribution these companies are making in the fight against the novel coronavirus epidemic in China and abroad.<\/p>

 <\/p>

According to reports, from March 23 Consular Corps in Guangzhou visited Guangzhou, Dongguan, and finally, Shenzhen to experience the major achievements of Guangdong Province during the 13th Five-Year Plan and the 14th Five-Year Plan period and see the future medium and long-term development prospects. They were introduced to the achievements of Guangdong Province in becoming a power source for high-quality development, strengthening intellectual property protection, encouraging independent innovation and development, promoting international cooperation in the fight against epidemics, and jointly building a community with a shared future.<\/p>


<\/p>

(Part of the material is reproduced from SHENZHEN SPECIAL ZONE DAILY, the original title is "Foreign Consulates in Guangzhou Visiting Shenzhen and Innovation is the Sign of this Great City")<\/span><\/p>


<\/span>
<\/p>


<\/p>


<\/p>"},{"id":"ff80808177f2643f0177f6dbce56000f","createTime":1611294600000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/archiveEn/acf1daa2-3e85-4b60-9893-12586d849f52.jpg","title":"Medcaptain has struck! New COVID-19 Diagnostics Solution receives CE Approval and is ready for export","subTitle":"Recently, Medcaptain has launched a new COVID-19 Diagnostics Solution which includes Neutralizing antibody test (CLIA), Rapid antigen test, Rapid antibody test, IgG test (CLIA) and IgM test (CLIA). ","html":"

\n Following a rebound in new coronavirus cases and the continuous deterioration of the epidemic situation in certain regions, as of 21st January 2021, there are over 413,000 new confirmed cases of COVID-19 worldwide in a single day. The total number of confirmed cases has reached 96,904,000 and the total number of deaths amounts to 2,071,000. The global epidemic prevention and control is once again at the highest emergency alert level. However, newly launched vaccines have brought a ray of hope in the midst of darkness and uncertainty.\n<\/p>\n

\n  \n<\/p>\n

\n The two-edged situation has brought up a long list of questions: What are the effective ways to detect the novel coronavirus? Do different stages of infection require different testing methods? Will the body acquire sufficient immunity to the novel coronavirus after vaccination? What is the way to confirm this?\n<\/p>\n

\n  \n<\/p>\n

\n All these issues can be combined into one major question: Is there an ultimate solution that can satisfy all these needs at once, from testing at different stages to confirming the immunity of the vaccinated person?\n<\/p>\n

\n  \n<\/p>\n

\n Recently, Medcaptain has launched a new COVID-19 Diagnostics Solution which includes Neutralizing antibody test (CLIA), Rapid antigen test, Rapid antibody test, IgG test (CLIA) and IgM test (CLIA). The solution has obtained CE certification and has been approved for export by the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE). In the field of COVID-19 diagnostics, Medcaptain is one of the first manufacturers to offer such a complete solution.\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
<\/span><\/strong>\n<\/p>\n

\n The First Certified Neutralizing Antibody Test (CLIA) from China<\/span><\/strong>\n<\/p>\n

\n
<\/span><\/strong>\n<\/p>\n

\n To provide an answer to the question whether people acquire immunity against COVID-19 after vaccination, Medcaptain has developed a Neutralizing Antibody Test, which is at the same time the World`s First Certified Test which adopts the Chemiluminescence Method.\n<\/p>\n

\n
\n<\/p>\n

\n When used together with Immu F6, the fully-automated Chemiluminescence analyzer will contribute to the fight against COVID-19 due to the following advantages:\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n Viral Test Solution | Identifying current COVID-19 infection<\/strong><\/span>\n<\/p>\n

\n
<\/strong><\/span>\n<\/p>\n

\n 1)       Rapid Antigen Test\n<\/p>\n

\n Device-free rapid antigen tests reveals if patients are currently in the infectious period by providing highly specific results within 10 minutes. Suitable for use in resource-limited settings.\n<\/p>\n

\n  \n<\/p>\n

\n 2)       RT-PCR Test\n<\/p>\n

\n PCR diagnostic solution provides reliable evidence of COVID-19 infection at the genetic level.\n<\/p>\n

\n
\n<\/p>\n\n \n \n \n \n
\n COVID-19 & Flu A & Flu B<\/span>\n            \n <\/td>\n \n Differentiate Flu A & Flu B from COVID-19 through only one test<\/span>\n            \n <\/td>\n <\/tr>\n
\n COVID-19 Triple (ORF1ab, N, S)<\/span>\n            \n <\/td>\n \n Detects 3 SARS-COV-2 genes, including the most specific S gene<\/span>\n            \n <\/td>\n <\/tr>\n
\n COVID-19 Dual (ORF1ab, N)<\/span>\n            \n <\/td>\n \n Detects 3 SARS-COV-2 genes<\/span>\n            \n <\/td>\n <\/tr>\n <\/tbody>\n<\/table>\n

\n
\n<\/p>\n

\n Serology Test Solution | Identifying previous COVID-19 infection<\/span><\/strong>\n<\/p>\n

\n  \n<\/p>\n

\n 1)       Rapid Antibody Test\n<\/p>\n

\n Device-free rapid tests provide fast answers regarding patient’s infection status within 10 minutes at different point of care locations.\n<\/p>\n

\n  \n<\/p>\n

\n 2)       IgG Test (CLIA)\n<\/p>\n

\n Performs reliable and rapid screenings of individuals through acridinium ester direct chemiluminescence technology.\n<\/p>\n

\n  \n<\/p>\n

\n 3)       IgM Test (CLIA)\n<\/p>\n

\n Performs reliable and rapid early screenings of individuals through acridinium ester direct chemiluminescence technology.\n<\/p>\n

\n *CLIA: Chemiluminescence\n<\/p>\n

\n  \n<\/p>\n

\n Relying on its strong R&D capabilities, Medcaptain has been in the IVD field for many years, and has been working relentlessly in the fields of coagulation and blood transfusion, immuno chemiluminescence and molecular diagnostics. As a result, we have launched a series of highly competitive products. In the field of COVID-19 testing, by providing novel coronavirus testing products to many countries and regions around the world, Medcaptain has contributed to the epidemic prevention and control on a global level.\n<\/p>\n

\n  \n<\/p>\n

\n We are always looking to contribute in a fight against the pandemic!\n<\/p>\n

\n
\n<\/p>\n

\n Learn more details：https://www.medcaptain.com/en/page?id=4028818775925d8e017593429fed0013&parentId=40288187759345bd01759360be9a0001<\/span><\/strong><\/a><\/span>\n<\/p>\n

\n
\n<\/p>\n

\n
\n<\/p>","title4model1":"","html4model1":"

\n Following a rebound in new coronavirus cases and the continuous deterioration of the epidemic situation in certain regions, as of 21st January 2021, there are over 413,000 new confirmed cases of COVID-19 worldwide in a single day. The total number of confirmed cases has reached 96,904,000 and the total number of deaths amounts to 2,071,000. The global epidemic prevention and control is once again at the highest emergency alert level. However, newly launched vaccines have brought a ray of hope in the midst of darkness and uncertainty.\n<\/p>\n

\n  \n<\/p>\n

\n The two-edged situation has brought up a long list of questions: What are the effective ways to detect the novel coronavirus? Do different stages of infection require different testing methods? Will the body acquire sufficient immunity to the novel coronavirus after vaccination? What is the way to confirm this?\n<\/p>\n

\n  \n<\/p>\n

\n All these issues can be combined into one major question: Is there an ultimate solution that can satisfy all these needs at once, from testing at different stages to confirming the immunity of the vaccinated person?\n<\/p>\n

\n  \n<\/p>\n

\n Recently, Medcaptain has launched a new COVID-19 Diagnostics Solution which includes Neutralizing antibody test (CLIA), Rapid antigen test, Rapid antibody test, IgG test (CLIA) and IgM test (CLIA). The solution has obtained CE certification and has been approved for export by the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE). In the field of COVID-19 diagnostics, Medcaptain is one of the first manufacturers to offer such a complete solution.\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
<\/span><\/strong>\n<\/p>\n

\n The First Certified Neutralizing Antibody Test (CLIA) from China<\/span><\/strong>\n<\/p>\n

\n
<\/span><\/strong>\n<\/p>\n

\n To provide an answer to the question whether people acquire immunity against COVID-19 after vaccination, Medcaptain has developed a Neutralizing Antibody Test, which is at the same time the World`s First Certified Test which adopts the Chemiluminescence Method.\n<\/p>\n

\n
\n<\/p>\n

\n When used together with Immu F6, the fully-automated Chemiluminescence analyzer will contribute to the fight against COVID-19 due to the following advantages:\n<\/p>\n

\n
\n<\/p>\n

\n \n<\/p>\n

\n
\n<\/p>\n

\n Viral Test Solution | Identifying current COVID-19 infection<\/strong><\/span>\n<\/p>\n

\n
<\/strong><\/span>\n<\/p>\n

\n 1)       Rapid Antigen Test\n<\/p>\n

\n Device-free rapid antigen tests reveals if patients are currently in the infectious period by providing highly specific results within 10 minutes. Suitable for use in resource-limited settings.\n<\/p>\n

\n  \n<\/p>\n

\n 2)       RT-PCR Test\n<\/p>\n

\n PCR diagnostic solution provides reliable evidence of COVID-19 infection at the genetic level.\n<\/p>\n

\n
\n<\/p>\n\n \n \n \n \n
\n COVID-19 & Flu A & Flu B<\/span>\n            \n <\/td>\n \n Differentiate Flu A & Flu B from COVID-19 through only one test<\/span>\n            \n <\/td>\n <\/tr>\n
\n COVID-19 Triple (ORF1ab, N, S)<\/span>\n            \n <\/td>\n \n Detects 3 SARS-COV-2 genes, including the most specific S gene<\/span>\n            \n <\/td>\n <\/tr>\n
\n COVID-19 Dual (ORF1ab, N)<\/span>\n            \n <\/td>\n \n Detects 3 SARS-COV-2 genes<\/span>\n            \n <\/td>\n <\/tr>\n <\/tbody>\n<\/table>\n

\n
\n<\/p>\n

\n Serology Test Solution | Identifying previous COVID-19 infection<\/span><\/strong>\n<\/p>\n

\n  \n<\/p>\n

\n 1)       Rapid Antibody Test\n<\/p>\n

\n Device-free rapid tests provide fast answers regarding patient’s infection status within 10 minutes at different point of care locations.\n<\/p>\n

\n  \n<\/p>\n

\n 2)       IgG Test (CLIA)\n<\/p>\n

\n Performs reliable and rapid screenings of individuals through acridinium ester direct chemiluminescence technology.\n<\/p>\n

\n  \n<\/p>\n

\n 3)       IgM Test (CLIA)\n<\/p>\n

\n Performs reliable and rapid early screenings of individuals through acridinium ester direct chemiluminescence technology.\n<\/p>\n

\n *CLIA: Chemiluminescence\n<\/p>\n

\n  \n<\/p>\n

\n Relying on its strong R&D capabilities, Medcaptain has been in the IVD field for many years, and has been working relentlessly in the fields of coagulation and blood transfusion, immuno chemiluminescence and molecular diagnostics. As a result, we have launched a series of highly competitive products. In the field of COVID-19 testing, by providing novel coronavirus testing products to many countries and regions around the world, Medcaptain has contributed to the epidemic prevention and control on a global level.\n<\/p>\n

\n  \n<\/p>\n

\n We are always looking to contribute in a fight against the pandemic!\n<\/p>\n

\n
\n<\/p>\n

\n Learn more details：https://www.medcaptain.com/en/page?id=4028818775925d8e017593429fed0013&parentId=40288187759345bd01759360be9a0001<\/span><\/strong><\/a><\/span>\n<\/p>\n

\n
\n<\/p>\n

\n
\n<\/p>"},{"id":"ff80808175f457fe017618d88519011b","createTime":1606735200000,"updateTime":1614755118000,"page":{"id":"8ee9b5b5babd424f8e4db8e3814dd8da","createTime":1591179958000,"updateTime":1604483354000,"htmlName":"","archivesLoadDepth":0,"imageUrls":"","name":"新闻资讯","templateFile":"page_news.jsp","archiveTemplateFile":"archive_article.jsp","pageSize":0,"archiveThumbnailWidth":0,"archiveThumbnailHeight":0,"html":"","name4model1":"News","templateFile4model1":"","archiveTemplateFile4model1":"","pageSize4model1":0,"archiveThumbnailWidth4model1":0,"archiveThumbnailHeight4model1":0,"html4model1":"","children":[]},"tagRecommend":false,"tagHot":false,"imageUrls":"/uploads/other/aba0b66d-105d-4cab-a259-196a6298601a.jpg","title":"Best Channel for Nutrition Delivery How COVID-19 Patients are Fed","subTitle":"Best Channel for Nutrition Delivery How COVID-19 Patients are Fed","html":"